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Overview 
This portfolio thesis comprises of three parts: a systematic literature review, an 
empirical report and appendices. 
Part one is a systematic literature review in which literature relating to the empirical 
paper is reviewed. Insufficient studies into hope in cardiac populations exist so the 
search was broadened to hope in chronic physical illness. The review attempts to 
determine what the strongest and most consistent correlated variables with hope are in 
chronic illness populations. Links to theory and recommendations for future research 
are then made. 
Part two is an empirical paper which includes two complementary studies. Study one 
aimed to test the hypothesis, what are the statistical predictors of hope. A range of 
variables were assessed to allow regression analysis with hope as the predicted variable. 
Study two explored the experiences of individuals living with cardiovascular disease 
and what made them hopeful about the future. The results of the two studies were 
formulated together to propose an understanding of the predictive processes present in 
hope. 
Part three comprises appendices and a reflective statement which draws on personal 
experience of and reflection on the research process. 
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PART ONE: 
 
 
 
Psychosocial Correlates of Hope in Individuals living with 
Chronic Physical Illness: 
A systematic review of published literature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This paper was written in accordance with the guidance for authors for the journal 
„Health Psychology Review‟ (Appendix 1) 
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Psychosocial Correlates of Hope in Individuals living with  
Chronic Physical Illness: 
 A systematic literature review 
Abstract 
Purpose: Hope is associated with positive outcomes in chronic illness but despite this, it 
is often poorly defined with little understanding of what maintains and fosters hope. 
Method: A systematic review assessing what psychosocial variables are correlated with 
hope in chronic illness populations was undertaken. Relevant publications were 
identified from a search strategy that encompassed 6 electronic databases, hand searches 
of 5 journals and reference lists of included articles. Results: 19 studies were eligible for 
inclusion. Significant correlations with hope were found for numerous psychosocial 
variables. The variables most consistently correlated with hope were low 
mood/depression, social support and anxiety. Inconsistent findings were found for 
quality of life, coping and spirituality. There was little to suggest that the methodology 
of the studies or the populations studied had a significant impact on the relationships 
observed. Conclusion: There are a number of variables that demonstrate consistently 
strong relationships with hope and these could be further developed into a predictive 
model of hope. Practically, interventions aimed at alleviating negatively correlated 
variables or promoting positively correlated variables of hope could be investigated 
with a view to improving health outcomes. 
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Introduction 
Chronic illness is “by far the leading cause of mortality in the world, representing 63% 
of all deaths”, (World Health Organisation [WHO], 2012). In the UK alone, 60% of 
adults report having a chronic health problem, with Diabetes, Chronic Obstructive 
Pulmonary Disease (COPD) and Heart Disease amongst the most commonly reported 
health conditions (Department of Health [DOH], 2004). It is also estimated that these 
figures are due to more than double for some populations within the next 20 years 
(DOH, 2004). The financial implications for this are massive, with the NHS currently 
spending approximately 70% of the patient care budget on treating and managing those 
with chronic illness (College of Medicine, 2011). In addition, with the drive to save £20 
billion by 2015 (DOH, 2011) it is now more vital than ever that new ways of helping 
people manage chronic illness are explored.  
 
Salutogenic theory and practice posits that health exists on a continuum between total ill 
health and total health, and to move towards a position of greater health, the promotion 
of positive assets is equally important as alleviating disease (Antonovsky, 1979). The 
approach focuses on the resources that exist within individuals, groups and systems 
which promote and maintain health (Antonovsky, 1979). These have been termed 
General Resistance Resources (GRRs) and are wide ranging in their scope, from genetic 
to psychosocial e.g. coping, intelligence and social capital (Antonovsky, 1979). GRRs 
can be employed dynamically and repeatedly to assist in movement towards total health 
(Lindström & Eriksson, 2005). There is a limited, but growing, evidence base for the 
positive health outcomes that can result from successfully employing GRRs (Morgan & 
Ziglio, 2007). Sense of coherence, the ability to use these resources, is strongly related 
to resilience and positive subjective state of health (Eriksson & Lindström, 2006). 
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Additionally, sense of coherence has been associated with lower risk behaviour 
(Bartley, 2006), lower stress (Amirkahn & Greaves, 2003) and lower anxiety (Hart, 
Hittner & Paras, 1991).  Over 20 different assets have been identified thus far and this 
review will focus upon one of those assets: hope. 
 
Hope has been defined as "a multidimensional dynamic life force characterized by a 
confident yet uncertain expectation of achieving good, which, to the hoping person, is 
realistically possible and personally significant” (Dufault & Martocchio, 1985, p 382). 
A prominent theory in hope is Snyder‟s work on constituents of hope and these are 
pathway and agency thinking (Snyder, 2002). Pathway thinking is the steps one needs to 
take towards a desired outcome while agency thinking is the motivation and confidence 
an individual has to use their pathway (Snyder, 2002). Salutogenesis draws on a similar 
theory when looking at the asset of hope, that is learned hopefulness. Learned 
hopefulness theory describes hope as a process which involves individuals learning and 
utilizing skills that imbue a sense of empowerment (Zimmerman, 1990).  This 
empowerment through hope is theorised to “limit the debilitating effects of problems in 
living” (Zimmerman, 1990, p 71). This theorised protective quality of hope has been 
found in a number of empirical papers. Higher levels of hope are correlated with lower 
severity and frequency of illness (Scioli, Chamberlin, Samor, Lapointe, Campbell & 
Macleod, 1997). In heart failure hope has been identified as a significant positive factor 
in illness trajectory (Davidson, Dracup, Phillips, Daly & Padilla, 2007), and has been 
found to be one of the most essential helpful elements identified in persons living with 
cancer (Buckley & Herth, 2004). 
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Despite the potential usefulness and positive impact of hope/hopefulness in chronic 
illness, hope is still poorly conceptualised, with little understanding of what maintains 
hope in those living with chronic illness (Wiles, Cott & Gibson, 2008). Hope is often 
viewed as elusive and mysterious, and little evidence has been found to aid in the 
fostering of hope, and by which more tangible means this could be achieved (Farran, 
Herth & Popovich, 1995). It is therefore important to try to understand what are the 
factors that are related to experiences of hope in people with chronic illness. If it is 
possible to clarify what factors are related to hope, then it may be possible to influence 
these with the intention of decreasing the individual, economic and societal burden of 
chronic illness. The aim of this review therefore is to systematically assess what are the 
significant psychosocial correlates of hope in chronic physical illness.  
 
Method 
Search Strategy 
Relevant journal articles were identified following a comprehensive search procedure 
which involved electronic databases, hand searches of reference lists of identified 
articles and subject relevant journals. The database searches were carried out in 
December 2011. The following electronic databases were searched: MEDLINE, 
CINAHL, PsycInfo, Scopus, Web Of Science and the Cochrane Library. The following 
journals were hand searched for additional articles that may not have yet been added to 
electronic databases: Health Psychology, Psychooncology, British Journal of Health 
Psychology, Journal Of Clinical Psychology in Medical Settings and Oncology Nursing 
Forum.
1
 The search strategy revolved around finding articles that focused on hope in 
                                                          
1
 The selected databases and journals were chosen to ensure that literature from medical, nursing and 
psychological disciplines were included as hope could be explored in any of these domains. 
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physical illnesses. As such the search terms were: (hope) AND (diseas* or ill* or heart 
or cancer* or neoplasm* or diabet* or arthriti* or cardiovasc* or renal or pulmonary or 
COPD or MS or "multiple sclerosis" or epileps* or hepatitis or AIDS or HIV or 
osteoporosis or colitis or crohn or lupus or pain) NOT (dement* or schizo* or autis* or 
degener*).
2
 Illness search terms were chosen on the basis of being identified as the most 
common chronic health conditions globally (WHO, 2011). The terms following the 
Boolean operator NOT were included to exclude results that were focusing on mental or 
degenerative illnesses. Studies into mental illness were excluded as the focus of the 
review was on physical illness, and degenerative illness studies were excluded because 
hope has been found to be experienced differently in those with terminal disease, with 
the focus becoming present rather than future focused (Herth, 1990)  
 
Selection Strategy 
A systematic review allows for any consistent correlates to be identified, should there 
be any. As such, the initial inclusion criteria were broad to ensure the capture of all 
potentially relevant articles. Titles and abstracts were included and full papers reviewed 
if the study involved exploring the relationship between hope and another psychosocial 
variable and a quantitative methodology was employed, due to correlational analysis 
being required to fulfil the purpose of the review.
3
  
 
All papers that met initial criteria were scrutinised and to be included in the review they 
needed to meet the following criteria: (1) the study was aimed at investigating a  
                                                          
2
 Terms were devised to ensure that the full range of physical illness was included in the search. Papers 
are often labelled with the illness term, rather than chronic illness, so it was necessary to include specific 
illness terms. 
3
 Quantitative methodology was chosen because the aim was to find consistent relationships, and to be 
able to compare between variables and populations so a standardised statistical approach was needed.  
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relationship between hope and other psychosocial variables; (2) the population was a 
patient one, not recovered individuals, carers, family or staff; (3) the population had a 
diagnosis of a physical illness; (4) the population was over the age of 18; (5) a 
quantitative methodology was employed; and (6) the articles were published in 
English.
4
 Papers were excluded if they: (1) were discussions and/or reviews; (2) 
employed measures of hope and other variables that were not psychometrically 
validated; (3) had populations with degenerative illnesses (e.g. dementia, Parkinson‟s 
etc.); (4) participants were receiving palliative care; or (5) did not report correlational 
analysis (Including p values).
5
  
 
Review Strategy 
A data extraction form was developed and applied to all articles that met the inclusion 
criteria. The information extracted from the articles was: population characteristics (age, 
gender, country, numbers, and diagnoses), study characteristics (design, hope measure 
employed, other psychosocial measures employed) and analysis (variables that did and 
did not correlate with hope).
6
 
 
A quality assessment checklist of 15 items was devised based on a number of other 
quality checklists already in circulation (Khan, Riet, Popay, Nixon and Kleijnen, 2001; 
National Institute for Health and Clinical Excellence: The Guideline Manual, 2007; 
                                                          
4
 Inclusion criteria 1, 2 3 & 5 were as a result of the aim of the review, criterion 4 was included because 
adult populations were of interest, criterion 6 was due to practical language issues 
5
 Exclusion criterion 1 was due to empirical research papers being required for the review. Criterion 2 
was included to ensure that the variables being reported had been validated and found to be reliable. 
Criteria 3 and 4 are included because hope has been found to differ in terminal illness.  Criterion 5 was 
included because the intended analysis required p values for comparison 
6
 See Appendix 2 for the data extraction form 
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Downs and Black, 1998, STROBE Initiative, 2008). 
7
 This was necessary because the 
studies included were not of an experimental nature, but rather were cross-sectional in 
design and execution.
8
 This checklist was piloted on a small randomly selected number 
of articles (n=5), both by the author and another independent rater, and was found to be 
satisfactory, both in discrimination and inter-rater reliability, so was applied to all 
included articles
9
. This process was essential to limit bias as well as allowing 
meaningful comparisons and conclusions to be made (Higgins & Green, 2011). For 
each quality assessment indicator a score of 1 was assigned if it was achieved. The 
following aspects of each paper were scored: Does the study have appropriate and 
clearly focused questions/aims?; are the main outcomes mentioned in introduction or 
method sections?; is there a clear conceptualisation/definition of hope?; is the 
population representative and relevant?; is the proportion of those who agreed to take 
part included?; are population characteristics clearly described?; are there clear 
inclusion/exclusion criteria?; is the response rate reported?; are the staff and 
places/facilities of care representative of care as usual?; is the hope measure 
appropriate?; are the psychometric properties reported?; if reported are they valid and 
reliable?; are the main findings clearly described?; is the data relevant to the review?; 
are the limitations of the research acknowledged?. Scores were totalled to create a score 
between 0 (poor quality) and 15 (highest quality).  
 
Procedure and data synthesis 
Full manuscripts of studies that met the initial inclusion were acquired and each was 
closely examined to determine if they met inclusion criteria. A meta-analysis was not 
                                                          
7
 See Appendix 3 for the quality checklist 
8
 The advantage of this was that the checklist was highly relevant to the studies included in the review. 
The disadvantage of this is that the checklist has not been validated, so could therefore be inaccurate 
9
 See Appendix 4 for inter-rater reliability scores 
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undertaken because the outcome measures employed were too heterogeneous to 
integrate statistically. For example, the most commonly investigated psychosocial 
variable (QoL) was only assessed in four of the included studies. Had there been more 
consistency in variables measured then a meta-analytic approach could have been 
employed.  
 
Results 
Trial Flow 
The initial search strategy generated 2092 potentially relevant citations. Of these 2028 
were omitted because they did not meet the initial inclusion criteria. The remaining 64 
papers were scrutinised to determine if the full inclusion/exclusion criteria were met. Of 
these 64 papers, 19 met the full inclusion criteria and were subjected to data extraction 
and included in the review. Hand searching of references of the included 19 papers and 
relevant journals did not provide any additional papers for inclusion. Figure 1 shows the 
output of the search strategy and reasons for exclusion. 
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Figure 1: Search Strategy 
Study characteristics 
Demographic characteristics 
A brief summary of included studies is shown in Table 1. Of the studies that reported 
participant age (N=15), mean age varied between 37 and 73 years (Alberto & Joyner, 
2008; Billington, Simpson, Unwin, Bray, & Giles, 2008; Crothers, Tomter, & Garske, 
2005; Fehring, Miller, & Shaw, 1997; Foote, Piazza, Holcombe, Paul, & Daffin, 1990; 
Frieson & Frieson, 1996; Gibson, 2003; Herth, 1989; Lin & Tsay, 2005; Parenteau, 
Gallant, Sarosiek, & McCallum, 2006; Post-White et al., 1996; Rustoen, Cooper, & 
Miaskowski, 2010; Staples & Jeffrey, 1997; Vellone, Rego, Galletti, & Cohen, 2006; 
Wang, Chang, Shih, Sun, & Jeng, 2006).  One study did not include participant gender 
information (Hsu, Lu, Tsou, & Lin, 2003), and of the remaining studies 16 included 
both gender participants. Two studies included only female participants, although the 
participant population were female breast cancer patients. (Gibson, 2003; Zhang Jing, 
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Gao Wei, Wang Ping, & Wu Zhong-hui, 2010). Proportion of male participants varied 
from 9% to 82% in remaining studies. Proportionally, females comprised the majority 
of participants, with only five studies reporting a greater proportion of male participants 
(Billington et al., 2008; Frieson & Frieson, 1996; Post-White et al., 1996; Staples & 
Jeffrey, 1997; Zhang Jing et al., 2010). Ten studies were undertaken in the United 
States, five in Asia (Taiwan = 4, China = 1), three in Europe (Italy = 1, Norway = 1, UK 
= 1) and one in Canada. Generalizability may be limited due to bias towards female 
participants and most research being conducted in the United States. However, wide 
variability in participant age and research being conducted across three different 
continents increases confidence in generalising findings. 
 
Design characteristics 
Apart from one study, which was longitudinal (Parenteau et al., 2006), all studies 
employed a cross sectional design. Sample sizes varied from 10 to 194 (mean 86). 
Three studies had sample sizes under 30 (Gibson, 2003; Parenteau et al., 2006; Staples 
& Jeffrey, 1997). The lone longitudinal study had follow up points at 3 and 6 months 
after baseline measurements (Parenteau et al., 2006). Four studies included comparison 
groups, one split by underlying medical condition (Parenteau et al., 2006), one with 
spouses (Staples & Jeffrey, 1997), one with presence of pain symptoms (Chen, 2003) 
and one with African-American and European-American groups (Gibson, 2003). 
Despite having comparison groups, analysis was undertaken as a whole in all studies, 
apart from Staples & Jeffrey (1997) in which patient and spouse correlates were 
calculated separately. 
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Recruitment characteristics 
All studies employed non-randomised convenience sampling and all recruited from 
either hospital or community health services which were reported to be representative of 
expected patient care. Ten of the 19 studies reported response rates (Alberto & Joyner, 
2008; Billington et al., 2008; Chen, 2003; Foote et al., 1990; Lin & Tsay, 2005; 
Parenteau et al., 2006; Post-White et al., 1996; Staples & Jeffrey, 1997; Vellone et al., 
2006; Zhang Jing et al., 2010) which ranged from 42% (Billington et al., 2008) to 95% 
(Lin & Tsay, 2005). 
 
Illness Characteristics 
Patient populations with a diagnosis of some form of cancer were studied in 63% of 
included studies. Two studies looked exclusively at breast cancer (Gibson, 2003; Zhang 
Jing et al., 2010) and one looked exclusively at lung cancer (Hsu et al., 2003).  Two 
studies drew participants from a renal failure population (Billington et al., 2008; Foote 
et al., 1990) and a further two sampled populations that were suffering from heart 
related diseases (Staples & Jeffrey, 1997; Wang et al., 2006). The final three studies 
sampled different illness populations: multiple sclerosis (MS) (Foote et al., 1990), 
chronic obstructive pulmonary disease (COPD) (Alberto & Joyner, 2008) and 
gastroparesis
10
 (Parenteau et al., 2006).  
 
Hope and Other Variable Measures 
The Herth Hope Index was the most widely employed hope measure being used by 63% 
of papers. The Miller Hope Scale was used in three studies (Fehring et al., 1997; Foote 
                                                          
10
 Partial paralysis of the stomach 
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et al., 1990; Frieson & Frieson, 1996) and a further three used the Herth Hope Scale 
(Felder, 2004; Herth, 1989; Post-White et al., 1996). The remaining three papers 
employed either the Snyder Trait Hope Scale (Billington et al., 2008), Snyder State 
Hope Scale (Parenteau et al., 2006) or the Nowotny Hope Scale (Vellone et al., 2006). 
All the hope measures employed have been demonstrated to have good reliability and 
validity.
11
 
 
A wide range of additional variables were measured, the joint most common being 
quality of life (QoL) with four studies either employing specific QoL measures or 
measures which had a QoL subscale within them (Billington et al., 2008; Post-White et 
al., 1996; Staples & Jeffrey, 1997; Vellone et al., 2006). Mood or depression was also 
measured by four papers, with three papers using a specific depression measure 
(Billington et al., 2008; Parenteau et al., 2006; Vellone et al., 2006) , and one using a 
measure of affect balance which measures balance between positive and negative 
emotions, with a negative result indicating depressed or low mood (Crothers et al., 
2005). Anxiety (Billington et al., 2008; Parenteau et al., 2006; Vellone et al., 2006), 
social support (Crothers et al., 2005; Foote et al., 1990)(Wang et al., 2006), spirituality 
(Fehring et al., 1997; Gibson, 2003; Post-White et al., 1996) and coping (Felder, 2004; 
Herth, 1989; Zhang Jing et al., 2010) were all investigated in three studies. Measures for 
self-care behaviour (Alberto & Joyner, 2008; Wang et al., 2006), self-esteem (Foote et 
al., 1990; Frieson & Frieson, 1996), sense of coherence (Gibson, 2003; Post-White et 
al., 1996), illness uncertainty (Hsu et al., 2003; Staples & Jeffrey, 1997) and 
psychological distress (Rustoen et al., 2010; Vellone et al., 2006) were included in two 
studies each. Single papers investigated the variables of optimism, perceived meaning 
of illness, religiosity and locus of control. At least one social variable such as 
                                                          
11
 See Appendix 5 for reliability and validity summaries of hope measures employed 
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socioeconomic status, marital status, education, years married or employment status 
were measured in 89% of studies. However, only two papers included any of these 
social variables in the correlational analysis (Lin & Tsay, 2005; Staples & Jeffrey, 
1997) . 
 
Quantitative Analysis 
Pearson‟s correlation was employed by all the studies included in the review. This is 
deemed an appropriate statistical test to ascertain the relationship between two variables 
within the same population when they are sampled using cross-sectional methodology. 
It allows for statistical determination of a significant relationship between two variables 
as well as the strength of that relationship. 
 
Quality assessment of the studies. 
Appendix 6 provides an overview of the quality assessment for included studies, using 
the quality checklist described above. For each of the 15 indicators one point was 
awarded if met by the study giving a possible maximum quality score of 15. Five 
studies achieved the maximum quality score of 15 (Billington et al., 2008; Felder, 2004; 
Foote et al., 1990; Staples & Jeffrey, 1997; Vellone et al., 2006). The majority of 
studies (52%) scored between 14 and 12 on the quality assessment checklist. Three 
studies scored either 10 or 11 on the quality assessment checklist (Crothers et al., 2005; 
Fehring et al., 1997; Parenteau et al., 2006). One study (Hsu et al., 2003) scored 9 out of 
15 on the checklist, which is the lowest score achieved by an included study. The main 
quality assessment items which were not met were reporting the proportion of people 
23 
 
approached who agreed to undertake the study (n=11), reporting the response rate (n=7) 
and reporting of sample inclusion or exclusion criteria (n=6). 
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Table 1: Characteristics of included studies 
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Findings of the hope correlate studies 
Unless otherwise stated all relationships reported are significant at the 0.05 level. 
Strength of relationships 
Only one measure in one study showed a very strong correlational relationship (r = ≥ 
0.9), which was a negative one between depression and hope at 6 month follow up in 
people with gastroparesis (r = -0.90) (Parenteau et al., 2006). Strong correlational 
relationships (r= ≥0.7 to ≤0.89) were found in eight cases. Two of these relationships 
were of measures of mood/depression, with both studies finding that hope was inversely 
correlated to depressed mood (Crothers et al., 2005; Parenteau et al., 2006). Anxiety 
was negatively correlated with hope at both baseline and 6 month follow up in people 
with gastroparesis (Parenteau et al., 2006).  In patients with cancer strong positive 
relationships were found between hope and coping response, spiritual wellbeing and 
existential wellbeing (Fehring et al., 1997; Herth, 1989). A strong positive correlation 
between hope and self-esteem in a MS population was also found (Foote et al., 1990).  
 
A further 25 moderate strength correlations (r = ≥0.4 to ≤0.69) were found. Three 
moderate positive correlations were found with reported social support received (r = 
0.42 to 0.68) (Crothers et al., 2005; Foote et al., 1990; Wang et al., 2006). Three 
moderate negative relationships were found for measures of depression (r =0.51 to -
0.63) (Billington et al., 2008; Parenteau et al., 2006; Vellone et al., 2006). Moderate 
relationships with hope were reported for quality of life (Billington et al., 2008; Vellone 
et al., 2006), spirituality (Fehring et al., 1997; Gibson, 2003) and anxiety (Parenteau et 
al., 2006; Vellone et al., 2006). All of these relationships were in the same direction, 
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with hope being positively correlated with quality of life and spirituality and negatively 
correlated with anxiety. Other variables that had moderate positive correlations with 
hope were optimism, religiosity, locus of control and sense of coherence. Moderate 
strength negative correlations with hope were reported for illness uncertainty, perceived 
meaning of illness and psychological distress. 
 
Consistency of relationships 
As previously reported, the variable included in the majority of papers was quality of 
life. In two studies hope was positively correlated with QoL, although these 
relationships were mostly weak (r = ≤ 0.39) (Billington et al., 2008; Vellone et al., 
2006). However, two papers found no significant relationship between hope and QoL 
(Post-White et al., 1996; Staples & Jeffrey, 1997). This inconsistent finding is not due 
to illness type, as both significant and non-significant relationships were found in a 
cancer population. Relationships between hope and mood/depression were more 
consistent across studies. Of the four studies that included measures of mood all found 
significant negative relationships between mood and hope, with correlations all being of 
at least moderate strength. This finding was over a number of illness populations, 
including cancer, renal failure and gastroparesis.  
 
Of the three papers that included an anxiety measure all found significant negative 
relationships with hope (r =  -0.37 to -0.75). Consistent positive relationships were 
found across the three studies that included measures of social support, all of which 
were of moderate strength. Inconsistencies were observed in both coping and 
spirituality. All studies that investigated coping were in cancer populations, and within 
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these studies a strong relationship (r = 0.80 (Herth, 1989)), a weak relationship (r = 
0.18, (Felder, 2004)) and a non-significant relationship (Zhang Jing et al., 2010) were 
observed. Spirituality showed a similar pattern, with a strong positive relationship (r = 
0.75, (Fehring et al., 1997)), a moderate positive relationship (r = 0.56, (Gibson, 2003)) 
and a non-significant relationship ((Post-White et al., 1996) with hope being reported. 
Again, all these findings were from cancer populations. 
 
Self-care, self-esteem and years in education were all positively correlated with hope 
across the two studies that measured each variable. Apart from one strong positive 
correlation between hope and self-esteem (r = 0.74, (Foote et al., 1990)), all other 
observed relationships were weakly positive (r = 0.39 to 0.21). Self-care and self-esteem 
were consistent between different illness populations, whereas both education 
correlations were observed in cancer populations. Consistent negative correlations were 
found for illness uncertainty and psychological distress, with r values between -0.30 and 
-0.56. Both psychological distress correlations were found in cancer populations while 
illness uncertainty was consistent across cancer and coronary artery disease populations. 
An inconsistent finding for sense of coherence was found across studies, with a 
moderate correlation found in one paper (r = 0.67, (Post-White et al., 1996)) and a non-
significant relationship found in another (Gibson, 2003). Both of these papers were 
investigating cancer populations, although the non-significant relationship was observed 
in a study which looked exclusively at a breast cancer population.  
 
Optimism was found to be positively correlated to hope (r = 0.59 (Alberto & Joyner, 
2008)) as was religiosity (r = 0.58, (Fehring et al., 1997)) and locus of control (r = 0.40, 
(Lin & Tsay, 2005)). The Perceived Meaning of Cancer Inventory employed in one 
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study produced a number of subscales, which produced varying correlations from 
positive (Challenge subscale, r = 0.44) to negative (Threat subscale, r = -0.40) (Chen, 
2003).  The only psychosocial variable found to have no relationship with hope was 
years married (Staples & Jeffrey, 1997). 
 
Discussion 
The most consistent and powerful negative correlations with hope was low 
mood/depression. Not only were all observed relationships from included studies in the 
same direction, they were also of at least moderate strength and consistent across a 
number of illness populations. From this it seems reasonable to postulate that low 
mood/depression and hope are likely to be negatively correlated across other chronic 
physical illness populations. It may be that depression inhibits experiences of hope 
and/or that hope is protective against low mood. For example, rumination whilst 
depressed could prevent forward thinking, or looking at the positives could attenuate the 
effects of negative thinking biases. The three papers that analysed the relationship 
between social support and hope found a similar consistent picture, again observing 
same direction relationships over a number of illness populations (heart failure, Cancer 
and MS). The same is true of the three studies which looked at anxiety and hope, with 
unidirectional relationships found across three different illness populations 
(Gastroparesis, Renal Failure and Cancer).  Social support and anxiety findings are not 
as robust as low mood/depression correlations due to two main reasons: observed 
relationships were not as strong and there were fewer papers investigating the constructs 
with fewer participants. Anxiety and social support do appear to be reliable correlates of 
hope, with anxiety being a more robust finding due to higher participant numbers and 
slightly stronger observed relationships. 
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While other consistent correlations were shown in the review they lacked the strength 
and applicability of those mentioned above. These consistencies were produced from 
two studies per variable. It is possible to hypothesise that the variables that showed 
consistent relationships could be significant correlates of hope, but due to the paucity of 
literature the strength of this hypothesis needs further empirical exploration. In relation 
to learned hopefulness theory it could be that the variables with significant relationships 
could be skills or resources that individuals can utilize to foster hope. Additional studies 
into these variables, such as self-esteem, self-care or illness uncertainty, could facilitate 
testing this hypothesis, especially if studies were conducted over a number of different 
illness populations. 
 
Due to inconsistent findings, some variables must be considered to not be reliable 
correlates with hope across illness populations, despite some strong relationships being 
observed in individual studies. A significant relationship with QoL was found in two 
studies, but no relationship in another two studies. This is particularly interesting 
because two of the studies that measured QoL were investigating cancer populations 
(Post-White et al., 1996; Vellone et al., 2006) and they found contradicting results. As 
such, the disagreement in findings, and particularly within the same illness population, 
means that QoL cannot be currently viewed as a variable that has consistent 
relationships with hope across illness populations. QoL could be considered the 
outcome of a number of different illness and psychological processes, and as such could 
be inconsistently related with hope due to other factors. The same conclusion can be 
drawn for spirituality and coping at this time. This is due to, despite three papers each 
investigating the variables, no agreement being reached on whether the relationship with 
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hope was significant or not. Additionally, as all the studies were investigating cancer 
populations, this disagreement was within the same clinical population. A possible 
explanation for this, especially in the case of spirituality, is the study characteristics. 
The non-significant relationship was observed in a small population (n = 32, (Post-
White et al., 1996)) whereas the significant relationships were found in a larger 
population (combined participant numbers = 110, (Fehring et al., 1997; Gibson, 2003)). 
It is also true for coping that greater combined participant numbers contributed to the 
significant relationships, but the study which found no significant relationship did also 
employ a large sample (n = 159, (Zhang Jing et al., 2010). It can only be concluded at 
this stage that both spirituality and coping cannot be seen as reliable correlates. More 
robust studies, with different illness populations, are needed in order to resolve the 
inconsistencies found in this review. 
 
All conclusions from this review need to be viewed in the light of the quality of the 
research from which they have been drawn. The majority of the studies were of good 
methodological and theoretical quality, with 79% of studies scoring 12 out of 15 or 
above on the quality checklist employed. All papers included reliable and valid 
measures of hope and correlational analysis that could inform the results and discussion 
of this review. Those studies which scored lower were due to omissions of 
inclusion/exclusion criteria, response rates and information regarding total numbers of 
participants approached. These quality shortcomings could potentially have resulted in 
populations that were biased, which could impact the validity of results. However, this 
seems unlikely as the findings from the four lowest quality papers (Crothers et al., 2005; 
Fehring et al., 1997; Hsu et al., 2003; Parenteau et al., 2006) all agree with findings 
produced by other studies with higher quality scores. An example of this is the -0.38 
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illness uncertainty relationship found by Hsu and colleagues (Hsu et al., 2003), which is 
similar to the -0.49 illness uncertainty relationship found by Staples & Jeffrey (1997). 
This similarity is despite a 6 point difference between the studies in terms of quality 
assessment. 
 
With the focus of the review being on correlation analysis it is important to consider the 
sample sizes involved in the calculation of r values. Some of the most robust findings, 
such as the strong correlations shown in individuals with gastroparesis (Parenteau et al., 
2006), were from relatively small samples. However, these findings have been 
supported by other studies with larger sample sizes (Billington et al., 2008 & Vellone et 
al., 2006). Additionally, contradictory findings in spirituality (Post-White et al., 1996)) 
and QoL (Staples & Jeffrey, 1997) came from small samples (n = <25). The influence 
of sample size has already been commented on as a possible explanation for the 
contradiction in the spirituality findings, but this sample size does not appear to be an 
influencing factor on the QoL findings because non-significant findings were found in 
an additional study and significant correlations were of low strength. 
 
Another area of consideration when interpreting the findings of this review are the 
measures of hope themselves. Two of the measures, the Snyder Trait and Snyder State 
Hope Scales, were not developed for use in illness populations and were not normed 
with illness populations. However, the findings of the papers that employed these 
measures (Billington et al., 2008; Parenteau et al., 2006) were supported by other papers 
that used measures that were developed with an illness population. All the measures 
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have been shown to be reliable and valid
12
 but the construct validity of the measures 
needs to be considered. A test of good construct validity is that measures show both 
convergent
13
 and divergent
14
 validity (Campbell & Frisk, 1959). A number of the hope 
measures used in the studies in the review have been found to highly correlate with each 
other (r = >.8) (Farran et al., 1995) indicating that the measures show convergent 
validity. However, divergent validity for hope measures is less evident. In the 
development of measures the majority of authors chose hopelessness scales to show 
divergent validity, and in this respect the measures showed good divergent validity 
(Farran et al., 1995). There is little comparison with other measures, both of positive 
and negative constructs. Therefore, there is a possibility of tautology within the 
measurement of the construct of hope. For example, the Herth Hope Index (Herth, 
1992) includes questions around loneliness and fear, which could be seen as part of the 
constructs of social support and anxiety respectively. Despite this potential for 
tautology, the argument can be made that only a few of the observed relationships with 
hope were of very strong or strong strength, indicating that what is being measured is a 
sufficiently different construct. 
 
This review, and its conclusions, show a number of limitations. Due to the focus of the 
review being correlations between hope and other psychosocial variables it is only 
possible to comment on which psychosocial variables are associated with hope, versus 
which variables predict or contribute to levels of hope. Only a small number of studies 
have employed regression analysis to look at predictor relationships in regard to hope 
(Berendes, Keefe, Somers, Kothadia, Porter & Cheavens,  2010; Farone, Fitzpatrick, & 
Bushfield, 2008).  Both studies looked at the relationship between hope and depression, 
                                                          
12
 See Appendix 5 for information regarding reliability and validity of hope measures 
13
 The extent to which measures of the same construct correlate with each other 
14
 The extent to which measures of one construct differ from measures of other constructs 
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with hope as an input variable, and both found that hope significantly predicted 
depression levels, with higher hope resulting in lower depression. While this is an 
interesting finding, it does not allow for conclusions about which variables affect 
experiences of hope in people living with chronic illness, especially as the few studies 
to conduct regression analysis did not include hope as an outcome variable. It would 
therefore be useful if future research could employ a regression analysis approach, but 
one in which hope is the outcome variable, so that it can be observed which of the 
variables that have been shown to correlate with hope actually predict it. If it were 
possible to determine what attributes or factors foster hope, then they can be encouraged 
and employed within clinical settings with a view to encouraging movement towards 
health. 
 
A further limitation is the illness populations investigated by the included papers.  Only 
6 broad illness populations were investigated (Cancer, renal, cardiac, MS, Gastroparesis 
and COPD). Notable omissions include diabetes, arthritis, HIV/AIDS and autoimmune 
diseases. As such, while collated findings can suggest that certain variables are 
consistent across a number of chronic illnesses, there are still numerous illnesses that 
have no research into the relationship between hope and other variables. Therefore, it is 
not possible to make a definite statement about the relationship across all illnesses, and 
a tentative position must be adopted. Further research is needed into additional illness 
populations. Whether or not these investigations would provide confirmation or conflict 
is unknown but it would be useful nonetheless because, if a future aim is to foster hope 
in chronic illness, it would be necessary to know which variables are significant for 
which populations. 
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In addition to the suggestions made previously, it would be recommended that once the 
additional suggested research has taken place, the literature is reviewed again with a 
view to constructing a theoretical model of hope for chronic illness. This would need to 
take into account the psychosocial variables mentioned within this review, as well as 
physical/biological factors, and how they predict and/or mediate the experiences of hope 
in people living with chronic illness. Hopefulness theory and sense of coherence could 
also be included in this i.e. looking at how resources and/or skills are employed to foster 
hope. A tentative position would be that depression and anxiety are detrimental to hope 
whilst social support and other variables such as self-esteem and self-care serve to 
facilitate hope. To build on existing theory, the negative correlates could prevent people 
from being able to take steps towards hope (i.e. they hamper agency thinking) while 
positive correlates could be resources individuals employ to increase learned 
hopefulness. Such a model would hopefully allow informed interventions tailored to the 
fostering of hope with the eventual outcome of improved physical and mental health. 
The importance of this is the potential huge cost saving to healthcare organisations, so 
any means by which health can be promoted would be beneficial, not just for patients 
themselves but the systems that treat them. 
 
In conclusion, this review suggests that low mood/depression shows the most consistent 
and powerful negative relationship with hope, with social support and anxiety the next 
most reliable relationships. Despite being studied by a number of papers, QoL was not 
found to have a consistent relationship with hope. Future research looking at wider 
illness populations and employing a regression analysis approach with hope as an 
outcome are recommended to fully understand the relationship between hope and other 
variables that exists within chronic illness populations. The incorporation of positive 
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constructs, not just hope, into research, both psychological and medical, may potentially 
lead to the discovery of means to develop total health for those suffering from chronic 
illness.  
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Predictors of Hope in Individuals living with Cardiovascular Disease 
Abstract 
Objective: Hope has been found to result in better health outcomes for individuals living 
with CVD, although it is currently unknown what factors predict hope. This study 
quantitatively examined predictors of hope for individuals with CVD, as well as 
systematically analysing experiential reports of predictors of hope. Methods: 112 
individuals living with CVD completed an online questionnaire which measured hope, 
depression, health-related quality of life, illness perception, locus of control and social 
support. A further 7 individuals completed a semi-structured interview which focused 
on their experiences of hope and what they had found helpful in building and 
maintaining hope. Results: All variables, apart from locus of control – powerful others, 
were found to significantly correlate with hope. Additionally, NYHA classification was 
found to be significantly related to hope. Depression was found to be the only 
significant predictor of hope following regression analysis. Following IPA of the 
interview transcripts three super-ordinate themes emerged in relation to predicting hope: 
finding and using inner resources, a positive and supportive environment and 
developing perspective and knowledge. Conclusions: Hope in CVD is a multi-faceted 
concept, inhibited by depression and fostered by personal and environmental resources. 
Detection and alleviation of depressed mood as well as the promotion of assets are 
important for maximising hope in this population. 
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Introduction 
Cardiovascular disease (CVD) is an umbrella term which covers a wide range of cardiac 
illnesses, such as coronary heart disease (CHD)
1
, cardiomyopathy
2
 and heart failure
3
. It 
is the biggest worldwide killer, accounting for 29% of global deaths yearly, with the 
number predicted to rise significantly in the future (WHO, 2010). In the UK, over 13% 
of the population have a diagnosis of some form of CVD (BHF, 2008), and it accounts 
for one third of deaths each year in the UK (BHF, 2010a) .The estimated cost  to UK 
health services is £14.4 billion with a further £16 billion of costs through lost 
productivity and informal care (BHF, 2010b). The majority of the expense to health 
services is from inpatient care and continued medication so any means to prevent 
readmissions and optimise self-management would be hugely beneficial. One approach 
to achieving this is to move away from a focus on problems and illness to focusing on 
positive assets and wellbeing
4
. 
Health has been theorised to exist on a continuum between total ill health and total 
health (Antonovsky, 1979). Salutogenic theory posits that the promotion of positive 
assets is equally important as alleviating disease in order to move towards better health 
(Antonovsky, 1979). The approach focuses on the resources that exist within 
individuals, groups and systems which promote and maintain health (Antonovsky, 
1979). Resources can range from genetic to psychosocial and have been term General 
Resistance Resources (GRRs) (Antonovsky, 1979). GRRs can be employed 
dynamically and repeatedly to assist in movement towards total health (Lindström & 
Eriksson, 2005). When employed successfully GRRs have already been shown to result 
in positive health outcomes (Morgan & Ziglio, 2007). The ability to use these resources 
                                                          
1
 Narrowing or blockages of coronary arteries 
2
 Deterioration in function of the heart muscle 
3
 Inability of the heart to supply sufficient blood flow to the body 
4
 See appendix 8 for an outline of positive psychology  
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(sense of coherence), is strongly related to resilience and positive subjective state of 
health (Eriksson & Lindström, 2006). Furthermore, lower levels of stress (Amirkahn & 
Greaves, 2003), anxiety (Hart, Hittner & Paras, 1991) and risk behaviour (Bartley, 
2006) are associated with an individual‟s ability to use their resources. A great number 
of assets have already been identified thus far, and this paper focuses on investigating 
one of these: hope. 
 
Hope has been defined as "a multidimensional dynamic life force characterized by a 
confident yet uncertain expectation of achieving good, which, to the hoping person, is 
realistically possible and personally significant” (Dufault & Martocchio, 1985, p 382). 
A well accepted view of hope is that it is constructed of pathway and agency thinking 
(Snyder, 2002). Pathway thinking is the steps one needs to take towards a desired 
outcome while agency thinking is the motivation and confidence an individual has to 
use their pathway (Snyder, 2002). Another understanding of hope, learned hopefulness, 
is one that has already been identified in salutogenic thinking. Learned hopefulness 
theory describes hope as a process which involves individuals learning and utilizing 
skills that imbue a sense of empowerment (Zimmerman, 1990). Through finding hope 
individuals are able to “limit the debilitating effects of problems” (Zimmerman, 1990, 
p71), be they mental or physical. Empirical study has already found evidence for the 
protective qualities of hope. Higher levels of hope are correlated with lower severity and 
frequency of illness (Scioli et al. 1997). In particular relevance to CVD, hope has been 
identified as a significant factor in illness trajectory following heart failure (Davidson, 
Dracup, Phillips, Daly & Padilla, 2007).  
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Despite the emerging evidence that hope can play a significant part in positively 
impacting CVD outcomes, there has been little research into the area. The majority of 
existing research focuses on the relationship hope has with other variables. For 
example, hope has been found to be significantly correlated with social support (Wang, 
Chang, Shih, Sun & Jeng, 2006) and health-related quality of life (HR-QoL) (Staples & 
Jeffrey, 1997) in CVD populations. In individuals with heart failure, self-assessed 
health and life satisfaction were found to be significant predictors of hope (Rustøen, 
Howie, Eidsmo & Moum, 2005). The measures employed in this study, however, were 
not validated and consisted of single Likert scale questions for both self-assessed health 
and life satisfaction.  Rustøen and colleagues (2005) are thus far the only researchers to 
have used regression analysis, rather than correlations, in their investigation into hope 
and CVD, which is something the current study has aimed to replicate. 
 
The current study had a hypothesis and an aim designed to answer the research question 
of what are the predictors of hope in individuals living with CVD. The hypothesis was 
that there would be significant predictors of hope in people living with CVD. It was not 
possible to identify what predictors of hope in a CVD population were, due to paucity 
and methodological shortcomings of existing research. It was, however, possible to 
identify what the most likely predictors may have been. The variables selected for 
investigation were locus of control, social support, illness perception, health related 
quality of life and depression. Social support and HR-QoL were chosen based on their 
already demonstrated relationship with hope within the CVD population (Staples & 
Jeffrey, 1997; Wang et al, 2006). LoC and illness perception were both identified as 
potential predictors due to cancer research identifying them as significantly related to 
hope (Chen, 2003; Lin & Tsay, 2005). Depression was selected because in other chronic 
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physical health conditions it has been found to have a strong relationship with hope 
(Billington, Simpson, Unwin, Bray & Giles, 2008; Crothers, Tomter & Garske, 2005; 
Parenteau, Gallant, Sarosiek & McCallum, 2006; Vellone, Rego, Galletti & Cohen, 
2006). Regression analysis was planned to be used to test this hypothesis. The aim was 
to uncover what themes individuals believe promote or sustain their experiences of hope 
would be present in subjective reports. It was thought that themes similar to the 
variables investigated in regard to the first aim would also be present in the subjective 
reports of hope given by people living with CVD. Interpretive Phenomenological 
Analysis (IPA) was planned to allow for testing of this hypothesis. The findings from 
the two hypotheses were compared for the purposes of triangulation and are discussed 
in relation to existing research and theory. 
 
Method 
Study Design 
To allow the research question to be answered two studies were conducted. Study 1 
employed a quantitative design and aimed to test the hypothesis. This was achieved 
through completion of an online questionnaire which included a range of variables. 
Study 2 was designed to investigate the aim and did so using qualitative methodology. 
This was achieved through semi-structured interviews with individuals living with 
CVD. 
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Participants 
Study 1: A sample of individuals living with CVD were recruited through CVD online 
forums and CVD
5
 charities. Exclusion criteria for the study were: age under 18 years 
old, a diagnosis of congenital heart disease, a diagnosis of serious mental health 
problems, a diagnosis of another serious on-going medical condition, e.g. cancer or 
diabetes, or were not English speaking. 
 
An advertisement
6
 was posted on online forums, included in newsletters or hosted on 
websites for 11 months between April 2011 and March 2012. It was not possible to 
determine the number of individuals who viewed the advertisement. It was however 
possible to count the number of individuals who visited the online questionnaire 
website. The total number of visitors was 140, and of these 112 completed the online 
questionnaire survey (80% response rate). The average age of participants was 59.0 
years (SD=12.7), with 49% being male. Country of residence was 49.1% in the United 
Kingdom, 43.8% in North America, 4.5 % in Australia and 2.7% in other countries. The 
sample was 94.6% white. Diagnoses were split between six main categories: Coronary 
Heart Disease (CHD)/Angina (41.1%); Heart failure (12.5%); Heart attack (15.2%); 
Cardiovascular/Atherosclerosis (14.3%); Cardiomyopathy (11.6%) and Sick Sinus 
Syndrome (SSS) (5.4%). Illness severity, as classified using the New York Heart 
Association (NYHA) Functional Classification
7
, for the sample was: Class I (29.5%); 
Class II (43.8%); Class III (24.1%) & Class IV (2.7%). The mean time since diagnosis 
was 85.5 months (SD=103.6) and 70.5% of the sample had experience of a friend or 
relative having some form of CVD. 
                                                          
5
 See appendix 9 for a list of contacted forums and charities 
6
 See appendix 10 for a copy of the online advertisement 
7
 NYHA Functional classification places patients in one of four categories based on limitations placed on 
physical activity by breathlessness and/or angina pain. NYHA classification is scaled from Class I (no 
symptoms or limitations) to Class IV (severe limitations, mostly bedbound) 
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Study 2: A sample of individuals living with CVD was recruited through heart support 
groups from 2 regional district hospitals in the north of England. Participants were 
subject to the same exclusion criteria as those participating in study 1. 
 
Over an 8 month period, August 2011 to March 2012, information sheets were 
distributed through heart support groups. Information sheets were provided to 71 
individuals. Of these 71, 7 individuals contacted the researcher and completed the semi-
structured interview (10% response rate). The average age of participants was 67 years 
(SD = 7.5), with 85% male. All participants resided in the United Kingdom. Diagnoses 
of participants were Angina (n = 4). Heart Attack (n = 2) and Cardiomyopathy (n = 1). 
NYHA Functional Classifications were as such; 3 participants were Class I, 3 
participants Class II and 1 participant Class III. Mean time since diagnosis was 147 
months (SD = 165.4), all participants were of White-British ethnicity and 85% of 
participants had experience of friends or relatives having CVD. 
 
Procedure and Measures 
The study was approved by a local research ethics committee
8
 and was peer reviewed 
by a university post-graduate department.  
 
Study 1: All participants were required to read an information sheet
9
 prior to providing 
informed consent through a tick box system
10
. The questionnaire
11
 was built and hosted 
on www.surveymonkey.com and comprised a number of measures: 
                                                          
8
 See appendix 11 for a copy of the ethical approval letter 
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Hope:  The measure of hope employed was the Herth Hope Index (HHI) (Herth 1992). 
This is a brief 12 item scale that assesses an individual‟s current hope. All questions are 
on a 4 point Likert scale ranging from Strongly Disagree to Strongly Agree. Scores 
range from 12 to 48 with a higher score meaning greater experiences of hope. The HHI 
has been used already in research into CVD (Rustøen et al, 2005) and has been shown 
to have high internal consistency (alpha = .97) and test-retest reliability (r = .91) (Herth, 
1992). 
 
Depression: The Cardiac Depression Scale (CDS) (Hare & Davis, 1996) is a 26 item 
scale which has been specifically designed to be sensitive to depressive symptomology 
in individuals with CVD.  Questions are on a 7 point Likert scale with appropriate 
anchors. The scale comprises of 7 subscales but for the purposes of this study the 
overall depression score calculated from all 26 items was used. Scores vary from 26 to 
182 with a higher score indicating higher levels of depressions. The CDS has good test-
retest reliability (r = .86) and high internal consistency (alpha = .91). The CDS has been 
validated in numerous languages and populations (Hare, 2010) and has high correlations 
with the Beck Depression Scale (r = .73) (Hare & Davis, 1996). 
 
Illness Perception: The Brief Illness Perception Questionnaire (BIPQ) was used to 
assess illness perception in this study (Broadbent, Petrie, Main & Weinman, 2006). The 
BIPQ is an abbreviated 8 item version of the Illness Perception Questionnaire. All items 
are scored on an 11 point Likert scale with appropriate anchors. Each item constitutes 
its own subscale although for the purpose of the current study the overall illness 
                                                                                                                                                                          
9
 See appendix 12 for Study 1 participant information sheet 
10
 See appendix 13 for Study 1 consent form 
11
 See appendix 14 for the online survey converted to text format 
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perception score was calculated. This is done by averaging the scores over the 8 items 
with a higher score meaning illness is perceived as more threatening (Broadbent et al., 
2006). The BIPQ has good test-retest reliability (r = .71), highly significant concurrent 
validity when compared to the full Illness Perception Questionnaire and good predictive 
validity in a variety of areas such as anxiety, return to work and quality of life 
(Broadbent et al., 2006) 
 
Health-Related Quality of Life: To assess HR-QoL participants completed the MacNew 
Health-Related Quality of Life Questionnaire (Valenti, Lim, Heller & Knapp, 1996). 
The MacNew is a measure of HR-QoL developed specifically for use in CVD 
populations. It consists of 27 items rated on a 7 point Likert scale which refer to 
limitations placed on emotional, physical or social QoL in the past 2 weeks. The 
MacNew consists of three subscales which correspond to the emotional, physical and 
social domains, although for the purposes of this study the Global HR-QoL scale was 
used. Internal validity has been demonstrated to be high (alpha = .95) as has construct 
validity (Valenti et al., 1996). 
 
Locus of Control: Participants completed the Multidimensional Health Locus Of 
Control Scale (MHLoC) (Wallston, Wallston & DeVellis, 1978). There are various 
forms of the MHLoC and the current study used Form A which is an 18 item scale 
containing three subscales: internal, powerful external others and external chance. These 
scales are not mutually exclusive, with high scores possible on multiple subscales. Items 
are scored on a 6 point Likert scale ranging from Strongly Disagree to Strongly Agree. 
Internal validity is high (alpha = .67 to .77), as is predictive validity for health status, 
although this varied across subscales (Wallston, Wallston & DeVellis, 1978). 
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Social Support: The Duke-UNC Functional Social Support Questionnaire (FSSQ) 
(Broadhead, Gehlback, Van De Gruy & Kaplan, 1988) was used to measure social 
support. The FSSQ is an 8 item scale that measures perceived social support and has 
been employed in a variety of illness populations and age ranges. Each item is scored on 
a 5 point Likert scale with appropriate anchors and then scores are averaged to gain an 
overall measure of social support, with higher scores indicating greater perceived social 
support. Test-retest reliability is good (r = .66) as is internal validity (alpha = .62). In 
addition to this, high correlations with a number of longer measures of social support 
have been found (Broadhead et al., 1988) 
 
In addition to the standardised measures completed, participants also provided 
demographic information. This included age, gender, country of residence and ethnicity. 
Information about participants CVD was also collected and this included diagnoses 
received, time since first diagnosis and self-rated NYHA Functional Classification. 
Finally, participants were asked if they had experience of friends or family being 
diagnosed with CVD prior to their own diagnosis. 
Study 2: Participants who wished to undertake the interview contacted the researcher 
using information provided on information sheets
12
 distributed to heart support groups. 
Informed consent was validated before the beginning of the interview through a consent 
form
13
. Prior to the completion of the semi-structured interview participants provided 
demographic and illness information identical to that provided in Study 1. Participants 
also completed the HHI. 
 
                                                          
12
 See Appendix 15 for Study 2 participant information sheet 
13
 See Appendix 16 for Study 2 consent form 
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The semi-structured interview
14
 consisted of 7 questions which can be seen in Table I. 
From each of these questions, additional open and exploratory questions were asked by 
the researcher to elicit further information.  
Table I: Question from the semi-structured interview in Study 2. 
Interview Questions 
What have your experiences of hope been since your diagnosis? 
Have you had times that you‟ve experienced low mood and has this affected any experiences of hope you have had? 
How do you see your illness and has this affected any experiences of hope you have had? 
How would you rate your current quality of life and has this affected any experiences of hope you have had? 
How in control of your illness do you feel and has this affected any experiences of hope you have had? 
What have been your experiences of receiving support from people you know and has this affected any experiences 
of hope you have had? 
Are there any other areas apart from those already discussed that you feel have had an impact on your experiences of 
hope? 
 
Data Analysis 
Study 1: It was calculated that a sample of at least 106 participants would be required to 
allow regression analysis with sufficient power (Tabachnick & Fidell, 2007). The 
normality of data was checked using Kolmogorov-Smirnov. Pearson‟s r correlations 
and one-way analysis of variance (ANOVA) were performed to check if any of the 
demographic or illness variables were significantly correlated with hope or significantly 
explained variance in hope. Any variables found to be significant in this analysis were 
included in the first block of the linear regression. Pearson‟s r values were also 
calculated between hope and the predictor variables. Any variables that were not 
significantly correlated, or that had r values greater than 0.9, were excluded from block 
                                                          
14
 See Appendix 17 for the full interview schedule 
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2 of the linear regression. Included variables were then used to perform the 2 block 
linear regression. 
 
Study 2: IPA was used because the aim was to uncover the predictive themes relating to 
hope in personal experiences of individuals living with CVD, which IPA could 
facilitate. Following completion of interviews they were transcribed and checked for 
accuracy. In addition, three participants
15
 checked that their transcripts were a true 
representation of their interview. IPA analysis followed guidelines described by Smith, 
Flowers & Larkin (2009). Transcripts were read and notes of interest were made in the 
left hand margin. This procedure was repeated several times by the researcher (male, 7 
transcripts) as well as a research supervisor (female, 3 transcripts) and a Trainee 
Clinical Psychologist (female, 4 transcripts). Initial notes were reviewed and emergent 
themes were recorded. These themes were discussed between the researcher and the co-
analysts. This process is consistent with recommended procedure to use supervision and 
collaboration to develop coherent interpretation (Smith, Flowers & Larkin, 2009), and 
also allowed for deeper exploration and validity checks. Three interviewees were 
contacted to provide member validation of the developed themes. These themes were 
compared across transcripts and were included in the analysis if they occurred in over 
half the sample. 
 
With IPA being a subjective process it is important to detail the assumptions of the 
researcher so that themes can be viewed in light of these assumptions. The researcher in 
this study entered with the assumptions that truth can exists in many forms, be it 
                                                          
15
 All participants were asked if they were willing to be contacted during analysis. 6 consented and 3 were 
chosen at random to be contacted in the analysis stage. 
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statistical or subjective, but that any form of truth does not take precedent over any 
other. Additionally, the researcher is interested in positive psychology and positive 
assets so is therefore biased towards the positive aspects of human experience. 
 
Results  
Study 1: Scale scores for all measures were calculated and can be seen in Table II. 
Cronbach‟s alpha was also calculated for the sample, with all scales showing good 
reliability (alpha = >0.7). All data were found to be normally distributed so parametric 
tests were employed throughout. One way ANOVAs were performed on hope with 
gender, country of residence, ethnicity, diagnosis, NYHA functional classification and 
experience of CVD as independent variables. Only NYHA functional classification was 
found to be significant (F(3,111) = 5.470, p = .002) with hope decreasing as severity 
increases. Pearson‟s r values were calculated for the relationship between age and hope 
and months since diagnosis and hope. Neither relationship was found to be significant. 
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Table II: Summary of variable scale scores for Study 1  
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SD 
38.41 
(4.88) 
90.89 
(22.92) 
38.03 
(12.49) 
5.09 
(1.12) 
23.44 
(6.35) 
17.72 
(6.36) 
19.57 
(6.41) 
4.05 
(0.84) 
Alpha .835 .890 .747 .954 .795 .766 .754 .889 
 
Correlations were calculated for the relationship between hope and the predictor 
variables (Table III). Only LoC Powerful Others was not significantly correlated to 
hope. All other relationships were significant at the 0.05 level. Additionally, no variable 
had an r value of over 0.9 so none were removed due to co-linearity.  
Table III: Pearson’s r values for the relationship between hope and the predictor 
variables 
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Pearson‟s r -.684* -.549* .577* .303* -.294* -.160 .448* 
*p < .05 
Regression analysis
16
 was performed to ascertain any significant predictors of hope. In 
the first block, NYHA functional classification was entered into the model. In the next 
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block, depression, illness perception, HR-QoL, LoC – Internal, LoC – Chance and 
Social support were entered (Table IV). NYHA functional classification was a 
significant predictor of hope in the first block, but only explained 4% of the variance in 
hope. When the other predictor variables were entered into the model, NYHA functional 
classification was no longer a significant predictor of hope. Only depression was a 
significant predictor of hope, with the total model explaining 51% of the total variance 
in hope. 
Table IV: Multiple regression summary table  showing effect of variables on hope 
(dependent variable) 
Block 1 
Variable R
2
 r Β Df F P 
Overall .04   1,110 5.004 .027* 
NYHA  -.21 -.21   .027* 
Block 2 
Overall .51   7,104 15.924 <.001* 
NYHA  -.21 .15   .083 
Depression  -.68 -.60   <.001* 
Illness Perception  -.55 .12   .463 
HR-QoL  .58 .19   .178 
LoC – Internal  .30 .12   .120 
LoC – Chance  -.29 -.03   .698 
Social Support  .45 .12   .172 
*denotes significance at the 0.05 level 
Study 2: The mean score for study 2 participants on the HHI was 40.4 (SD = 3.98, alpha 
= 886), indicating a high level of hope. Following IPA analysis
17
, three super-ordinate 
themes were evident, and these occurred in all of the transcripts. Within these three 
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 See appendix 19 for an example of worked IPA theme development 
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super-ordinate themes a number of associated sub-themes were identified, and can be 
seen in Table V. No apparent hierarchy of importance was indicated by participants. To 
aid in the understanding of these themes and how they relate to experiences of hope a 
theme of „What Hope Is‟ was developed. This consists of a number of elements such as 
living well with my illness: “it‟s a part of me now and I‟ll live with it” (P5, 12), looking 
to the future: “seeing the grandkids grow up, that‟d be grand” (P6, 15), knowing the 
steps necessary to go forward: “if I stay active then I might get back to work” (P1, 24) 
and keeping at it: “I‟ll have set backs, and I already have, but it doesn‟t stop me” (P3, 
34). The three super-ordinate themes refer to what participants felt helped them form 
and sustain this view of hope. 
Table V: Super-ordinate themes and associated sub themes identified as predictors of 
hope 
Super-ordinate themes and associated sub themes 
Finding and using inner resources A supportive and positive 
environment 
Developing perspective and 
knowledge 
Mental strength Family support Knowing your limits 
Taking control of my illness Using experts Timescales 
Being able to trust in others Social consistency Realistic perceptions 
Staying active Modelling Congruence of needs 
Adaptability  Seeing the big picture/stoicism 
  Recognising recovery 
 
When questioned about what made participants hopeful all identified that finding and 
utilising inner resources was an important factor. By being able to employ a variety of 
inner resources individuals felt more hopeful and confident in their ability to maintain 
hope and health. Mental strength was identified as the ability to keep positive in the face 
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of difficult circumstances. Beliefs such as “if you let that [the head] go, then that‟s dead 
[the heart]” (P4, 26) and “I won‟t be beat” (P5, 48) are formed that help individuals 
overcome difficult times and remain hopeful. The ability to take control of one‟s own 
illness was also significant; “it‟s down to people to decide for themselves what to do” 
(P3, 268). Trusting in others, particularly during difficult times was raised in most of the 
transcripts: “give my body over to the doctor and let him deal with it…I did that” (P7, 
69), “you just place your trust in their hands” (P1, 399). The importance of staying 
active and trying to live as normal as possible was identified by all participants in their 
transcripts. Excerpts such as “I still carried on with what I was doing e.g. golfing, 
gardening, walking…” (P6, 105) highlight the role that maintaining an active lifestyle 
has upon keeping individuals hopeful for the future. A final sub theme of finding and 
using inner resources was adaptability. All participants commented on having to make 
adaptations to their lifestyle following their diagnoses, and how being able to positively 
adapt to their circumstances fortified their feelings of hope. “I had to take time off 
work…but I carried on strong” (P3, 221), “I‟ve got more confident…I don‟t stand back 
and wait” (P7. 148) and “if it‟s very cold at the football I have to get double wrapped up 
now” (P2, 193) are just a few of the examples produced about making adaptions in light 
of illness, but are all instances where positive outcomes have been produced. 
 
The second super-ordinate theme was a supportive and positive environment. This was 
constituted mainly of constructive relationships that helped individuals feel hopeful and 
maintain hope in the face of difficulties. The support offered from family members as a 
means to become hopeful was identified by all interviewees; “they‟ve always been there 
for you” (P5,198), “how would I have survived on my own? I wouldn‟t have done” (P1, 
277), “family and friends wanting you to get back to normal. That goes a long way” 
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(P1,497). Using experts, both at times of crisis and as sources of information about 
illness, was another identified facet of the supportive and positive environment. 
Statements such as “I‟m doing what the doctors tell me” (P6, 129), “I had every faith in 
the medical professionals” (P2, 225) and “you get the information from the specialist 
about…what you can do” (P3, 263) were common in this sub theme. A sense of social 
consistency was identified as helpful i.e. social activities and interactions occurring the 
same as they did prior to any illness; “they never stopped inviting me” (P1, 493). The 
final facet of the supportive and positive environment was individuals having 
experiences of positive modelling of recovery from those around them;  “The workman 
said ”I had one [a heart attack] three years ago” and with that he shoved a boiler on his 
back ” (P2, 38). 
 
The final super-ordinate theme was developing perspective and knowledge as a means 
to promoting hope. By developing a positive position in regards to their illness as well 
as specific, helpful knowledge interviewees reported that they were able to feel more 
hopeful about their situations and their futures. Knowing their own limitations 
following their diagnosis and treatment was identified by all participants as an 
important factor in promoting hope; “I know my limitations now” (P5, 74), “I‟m 
sensible in what I can and cannot do” (P7, 76). Having an understanding about the 
timescale of recovery, particularly in the acute phase following surgery, helped 
individuals create an understanding of their path to recovery and this fostered 
experiences of hope; “just got to realise that it does take time…which I didn‟t realise at 
the time” (P1, 515). In addition to this, having a realistic perception of their illness and 
what its impact on the rest of their life is going to be was an important aspect of 
developing perspective and knowledge; “you realise you have a limited life 
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expectancy…if everything goes well you‟re looking at 35, 40 years of life ahead” (P2, 
447). There is the recognition that at different stages of illness an individual will have 
different needs. If the care and support provided is congruent with the needs of the 
individual at that point then that is a facilitator of hope, however, if the support does not 
match the needs this can elicit feelings of frustration and hinder hope. For example, 
when there is congruence with needs; “I‟d say “a little further” and the wife would say 
“now, you‟ve got to get back”, it‟s a good reminder” (P5, 93), it is a positive 
experience, but when there is incongruence; “frustrating, them trying to slow me down” 
(P3, 145), positivity and hope are hindered. Being able to see one‟s illness as part of the 
bigger picture and approaching this in a stoic manner was another theme that helped 
individuals find hope; “It‟s logical isn‟t it? It runs in families, but you get on with it” 
(P7, 81), “it‟s a hazard of life. A bump in the road, that‟s all” (P3, 56). The final facet, 
and possibly the most frequently identified by interviewees, is recognising recovery. 
This is the process of seeing, measuring and appreciating the distance one has travelled 
in their recovery, particularly in light of current functioning versus post-
operative/diagnosis functioning. “It [the operation] made a complete new man of me” 
(P6, 15) and “I was able to walk a bit further and when I could drive. It was all 
milestones on the way to recovery” (P1, 72) are some examples of this theme. 
 
Discussion 
This study investigated predictors of hope in individuals living with CVD. The  
hypothesis was that there would be significant predictors of hope in individuals living 
with CVD. Study 1 found that depression was the only significant predictor of hope, 
and that it was inversely predictive. It can therefore been seen that depression is an 
inhibitor of hope in individuals with CVD. The reason for this may be that the 
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symptoms of depression are incompatible with the way hope is structured. Recognised 
cognitive components of depression include a negative view of the self, world and 
future and memory bias toward negative events (Carr & McNulty, 2006). This 
combined with withdrawal and low energy levels could serve to inhibit the processes 
involved in forming hope. According to recognised theory, the process of forming hope 
is an active one that requires forward thinking to form a pathway and then motivation 
and confidence to follow that pathway (Snyder, 2002). It could be seen that the 
processes that accompany depressed mood would serve to inhibit one‟s ability to form 
and follow through with hopeful thinking. This is in keeping with existing theory that 
hope and depression are distinct constructs, with depression disrupting hopeful goal, 
pathway and agency focused thinking and action (Cheavens, 2000).  
 
The aim was that themes of what individuals believed promoted their experiences of 
hope would be uncovered from subjective reports. These themes were identified as 
finding and using inner resources, a supportive and positive environment and 
developing perspective and knowledge. The positive slant of these themes is probably 
indicative of hope being a positive construct. The first theme, inner resources, could be 
directly linked to Zimmerman‟s notion of learned hopefulness (1990). Individuals could 
locate skills and resources within themselves that helped them find hope, which is how 
Zimmerman conceptualised the process of hope forming. These inner resources could 
also be seen as comparable to agency thinking in Snyder‟s hope theory (2002), i.e. they 
are the resources needed to follow the identified pathway. As hope is conceptualised as 
an internal process the other themes could be seen to augment this process. A supportive 
environment could be employed to help the development of these internal skills or to 
help sustain people in the face of difficulties. Perspective and knowledge could serve to 
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create an accurate perception of the challenges yet to be faced which could imbue drive 
and focus in the development and application of inner resources. Additionally, through 
retrospective processes they could reinforce the confidence they have in their ability to 
overcome difficulties and stay hopeful. This combination all identified themes 
contribute to one‟s experiences‟ of hope. 
 
Due to two studies being conducted it is possible to triangulate findings to see if they 
show any agreement. At face value, it would appear that there is no agreement between 
these two studies. However, this does not equate to them being unrelated. Instead the 
disparate results highlight the diverse nature of hope. Those interviewed for the 
qualitative section all had high levels of hope (mean = 40.4). If, as previously 
suggested, depression is inhibitive of hope then it would be expected that those 
individuals with high levels of hope would be relatively free from depressed mood. It 
would be predicted that if interviews and subsequent IPA were carried out with 
participants who had low levels of hope then depression would emerge as an important 
contributor, albeit a negative one, to their experiences of hope.  
 
In addition to relating to existing theory on hope the findings of this study are also 
worth comparing to salutogenic theory. As mentioned earlier, GRRs are employed to 
move towards total health, with one aspect of this being hopefulness. Numerous assets 
are involved in this process and many of the identified processes in this study can be 
linked to those already identified. Whilst depression is not identified as a salutogenic 
concept, there are numerous resources which could be seen to counteract depression, 
such as hardiness, coping, wellbeing and optimism (Eriksson, 2011). In direct relation 
to the positive predictors identified in Study 2, related identified resources could include 
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connectedness, resourcefulness, self-efficacy, attachment, inner strength and personal 
growth. Salutogenic theory already recognises that the processes that contribute to 
health are inter-connected (Lindstrom & Eriksson, 2005) and it could be concluded that 
the same is true for hope i.e. that it is intimately related to other positive factors within 
an individual and their environment. While there is the risk that by taking this positive 
stance the inhibitors (such as depression) are ignored, it is important to bear them in 
mind alongside positive contributors, especially as many of the positive contributors 
could also serve to alleviate depressed mood.  
 
This study builds on the small, but increasing body of literature on hope in CVD 
populations. Findings show agreement with previous research in so far as significant 
relationships between hope and LoC, HR-QoL, Illness Perception and Social support 
were replicated. There were however, several areas of disagreement with the previous 
research (in particular the regression study by Rustøen and colleagues (2005)). Firstly, 
in this study a significant relationship between NYHA functional classification and 
hope was observed, but this was not the case in their work. The possible reason for this 
is the difference in the samples. In this study nearly 75% of respondents had NYHA 
classifications of Class I or II, whereas in Rustøen and colleagues‟ (2005) study only 
19% of respondents were of Class I or II. It is possible that as illness severity increases 
hope is less variable. When there are fewer symptoms it would appear that what 
symptoms do exist impact significantly upon hope. Secondly, life-satisfaction was 
identified as a predictor of hope, whereas in this study the comparable variable, HR-
QoL was not a significant predictor. This may be due to these being different concepts 
but is more likely due to the means of measurement applied to each variable. In the 
current study a psychometrically validated questionnaire was employed to measure the 
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variable, whereas in Rustøen and colleagues‟ (2005) work the variable was measured 
using a single Likert question.  
 
Additionally, it is interesting to compare the results of this study with two regression 
studies involving depression and hope (Berendes et al., 2010; Farone, Fitzpatrick & 
Bushfield, 2008). Both studies took place in cancer populations and used hope as a 
predictor. Both found that hope significantly inversely predicted depression. This 
strengthens the view that depression and hope are inversely connected in chronic illness. 
However, in both cases when hope was the predictor, the percentage of variance 
explained was lower than the current study (31% and 13% versus 51% in the current 
study). This could be due to population differences or could be as a result of depression 
being more powerful as a predictor than as an outcome. 
 
There are multiple clinical implications that can be proposed from the results of the 
current study. The first and most significant implication is that depression should be 
frequently screened for in individuals living with CVD. As hope has already been 
demonstrated to result in better illness outcomes it is important to resolve any 
difficulties that would inhibit it, namely depression. Better identification of depression, 
at point of diagnosis and on-going throughout illness course, could identify those 
patients experiencing depressive feelings or negative thinking and direct them towards 
appropriate support. There are already many well defined and efficacious treatment 
options available for individuals experiencing depressed mood (NICE, 2009). The 
monitoring of low mood could be carried out by any number of professionals, from 
cardiologists and GPs, to nurses and rehabilitation workers. A second clinical 
implication is in the rehabilitation offered to individuals with CVD. It is already 
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recommended and demonstrated that rehabilitation is an efficacious and cost-effective 
intervention for individuals with CVD (BHF, 2007). Alongside the support and lifestyle 
interventions already offered it may be potentially helpful to include elements of the 
helpful mechanisms identified in Study 2. For example, positive models could be 
introduced, individuals could be encouraged to recognise how far they have come in 
their recovery or means for individuals to take more control of their illness could be 
developed. By adding these, and other indicated processes, to existing programs of 
rehabilitation it may be possible to foster feelings of hope in individuals living with 
CVD and therefore achieve the health benefits that accompany this. 
 
While a strength of the study is that standardised measures were used to obtain reliable 
measures of the predictor constructs it should be noted that the data is cross-sectional, 
so while regression analysis was possible it was not possible to track the influence of 
these variables on hope over time. This would not be overly difficult to remedy in future 
research, requiring baseline measures at diagnosis then follow up over time, possibly 
every 6 to 12 months. There would, however, have to be numerous illness measures as 
individual recovery would greatly differ and potentially confound findings. The same 
limitation and remedy can also be said of Study 2. It would be interesting to have a 
series of interviews with individuals throughout their rehabilitation to see if themes are 
more prominent at certain times or if themes differ throughout the course of 
rehabilitation. Another limitation is the use of self-report in terms of NHYA functional 
classification. As NYHA classification is based on estimates of functional impairment 
and symptom severity it is possible that individuals may over or under-estimate their 
classification. The addition of an objective measure of illness severity would have 
enhanced the current study. A final limitation results from the selection of predictor 
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variables.  Following the design of this study a systematic literature review identified 
anxiety as a significant correlated variable with hope in chronic illness (Forster, 2012). 
Anxiety may therefore be an additional predictor of hope, or may help explain more 
variance in hope than the model in this study. Inclusion of anxiety as a variable in future 
research would be recommended. 
A final consideration is potential tautology within the measure of hope itself. The HHI 
(Herth, 1992) includes questions about loneliness and memory for past events which 
could be seen as overlapping with social support and depression respectively. As such it 
could be that what was thought to be a measure of hope was in actuality a measure of 
other constructs. This does not however seem to be the case in the current study as the 
correlations between the HHI and the other measures, while significant, were of 
moderate strength at best. This suggests that whilst there may be some overlap, as is 
common with many psychometric measures, that the HHI is measuring a distinct 
construct that id different from the other measures in the study. 
The generalisability of the findings is limited by two main factors. Firstly, the data 
collection method for Study 1 consisted of an online survey which was advertised 
through online heart support forums. While this did enable collection of data from a 
variety of diagnoses and residences, it was only open to those with internet access and 
more specifically to those who were already accessing online support forums. As such, 
the sample was self-selecting from an already engaged population. In future work it 
would be beneficial to attempt to include a wider range of participants recruited through 
many different means to ensure generalisability. It would also be interesting to see if 
there were differences between community and hospitalised patient groups. Secondly, 
the participants for Study 2, from whom the super-ordinate themes were generated, all 
had fairly high levels of hope, consequently the themes identified may not apply to 
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individuals who are not hopeful. Including a sample of low hope individuals into the 
IPA analysis would allow for the construction of super-ordinate themes to take into 
account a wider range of patient experience. 
 
The current study has demonstrated that depression is inversely predictive of hope in 
individuals living with CVD. In addition, themes pertaining to the creation and 
maintenance of hope were identified from subjective experience. Thorough screening 
and early intervention for depression as well as the incorporation of promoting positive 
assets into rehabilitation programs, hope could be better fostered, with concomitant 
health benefits. Further longitudinal investigation is suggested to fully develop 
understanding of the processes involved and how they may change over time and illness 
course, which again may prove influential in informing cardiac care and rehabilitation. 
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Association (APA), Sixth Edition. Pages should be numbered consecutively and 
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should also include an author note with authors' full affiliations and the address for 
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will be useful for indexing or searching should be included. 
 
Manuscript length 
There is no formal word limit for manuscripts. Submissions should, however, be as long 
as necessary and authors of submissions of excessive length which do not covey ideas 
and points succinctly and concisely will be asked to truncate their manuscript. We also 
draw authors' attention to the Health Psychology Review online repository of 
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are too long for the print version of the journal (e.g., oversized tables, intervention 
protocols, questionnaires etc.) but to which authors of articles appearing in Health 
Psychology Review wish readers to have access. 
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Figures should be in a finished form suitable for publication and should be numbered 
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Appendix 2 
Data extraction form 
Study Title 
 
 
 
 
 
 
Author(s) and Year of Publication 
 
 
 
 
 
 
Participant Characteristics 
 
 
 
 
 
 
Hope measure 
 
 
 
 
 
 
Psychosocial variables measures 
 
 
 
 
 
 
Reported r values 
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Appendix 3 
Quality assessment checklist (adapted from Khan, Riet, Popay, Nixon and Kleijnen, 
2001; National Institute for Health and Clinical Excellence: The Guideline Manual, 
2007; Downs and Black, 1998, STROBE Initiative, 2008) 
 
1. Does the study have appropriate and clearly focused questions/aims? 
2. Are the main outcomes mentioned in introduction or method sections? 
3. Is there a clear conceptualisation/definition of hope? 
4. Is the population representative and relevant? 
5. Is the proportion of those who agreed to take part included? 
6. Are population characteristics clearly described? 
7. Are there clear inclusion/exclusion criteria? 
8. Is the response rate reported? 
9. Are the staff and places/facilities of care representative of care as usual? 
10. Is the hope measure appropriate? 
11. Are the psychometric properties reported? 
12. If reported are they valid and reliable? 
13. Are the main findings clearly described? 
14. Is the data relevant to the review? 
15. Are the limitations of the research acknowledged? 
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Appendix 4 
Inter-rater reliability 
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Appendix 5 
Hope measures employed by systematic literature review studies: characteristics, 
consistency and reliability 
 
Measure No. 
Questions 
Question 
type 
Minimum 
score 
Maximum 
score 
Consistency 
(alpha) 
Reliability 
(r) 
Herth Hope 
Index 
12 4 point 
Likert 
12 48 .97 .91 
Miller Hope 
Scale 
40 5 point 
Likert 
40 200 .93 .82 
Herth Hope 
Scale 
30 4 point 
Likert 
30 120 .94 .91 
Snyder Trait 
Hope Scale 
12 8 point 
Likert 
8 96 .78 .82 
Snyder 
State Hope 
Scale 
6 8 point 
Likert 
8 48 .84 .85 
Nowotny 
Hope Scale 
29 4 point 
Likert 
29 116 .90 .81 
 
Herth, K. (1991). Development and refinement of an instrument to measure hope. 
Scholarly Inquiry for Nursing Practice, 5 (1), 39-51. 
Herth, K. (1992). Abbreviated instrument to measure hope: development and 
psychometric evaluation. Journal of Advanced Nursing, 17, 1251–9. doi: 
10.1111/j.1365-2648.1992.tb01843.x 
Miller, J. F. & Powers, M. J. (1988).  Development of an instrument to measure hope. 
Nursing Research, 37 (1), 6-10.  doi: 10.1097/00006199-198801000-00002 
Nowotny, M. L. (1989). Assessment of hope in patients with cancer: development of an 
instrument. Oncology Nursing Forum, 16 (1), 57-61. 
Snyder, C. R. (2000). Handbook of Hope: Theory, measures, and applications. San 
Diego: Academix Press Inc 
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Appendix 6 
Quality assessment of included studies 
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Appendix 7 
Guidelines for authors for the journal „Health Psychology‟ 
The page limit for research manuscripts is 25–30 pages. The page limit is inclusive of 
all parts of the manuscript, including the cover page, abstract, text, references, tables 
and figures. 
Authors may request consideration of longer papers, in advance of submission, when 
there is clear justification for additional length (e.g., the paper reports on two or more 
studies or has an unusual or complex methodology). 
Scholarly reviews and meta-analyses should not exceed 25 pages, but tables and 
references may be outside this page limit. 
Brief reports are encouraged for innovative work that may be premature for publication 
as a full research report because of small sample size, novel methodologies, etc. Brief 
reports should be designated as such and should not exceed a total of 12 pages, 
inclusive of all parts of the manuscript, including the cover page, abstract, text, 
references, tables and figures. 
All manuscripts should be double-spaced, with margins of at least 1 inch on all sides 
and a standard font (e.g., Times New Roman) of 12 points (no smaller). 
Health Psychology considers letters concerning previously published articles. Letters 
should be no more than 500 words and have a maximum of five references. 
Authors also have the option of placing supplemental materials online. 
Submissions that exceed the page limits will be returned to the author for shortening 
prior to the initiation of peer review. 
Submission Letter 
The cover letter should indicate that the authors have read and followed the Health 
Psychology Instructions for Authors. It should also include a statement indicating that 
the paper has been seen and approved by all authors. The cover letter should describe 
how the paper advances research in health psychology, referring to the journal mission 
to assure that the submission fits with the types of papers published in Health 
Psychology. 
The full mailing address, telephone, fax, and email address for the corresponding author 
should be included in the cover letter, along with the names and affiliations of all co-
authors. 
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The cover letter must confirm that the manuscript has not been published, is not 
currently submitted elsewhere, and that it does not contain data that is currently 
submitted or published elsewhere. 
When a manuscript contains data that is part of a larger study, authors should describe 
the larger study and provide references for other study papers. Authors must be prepared 
to provide copies of related manuscripts when requested as part of the editorial review 
process. Authors should clarify the relationship between their paper, including detailed 
specification of the overlap in participants, measures, and analysis, and others from the 
study. The value-added scientific contribution of their study must be clearly stated in 
the cover letter. 
Authors of brief reports should indicate in the cover letter that the full report is not 
under consideration for publication elsewhere and similarly address potential overlap 
with other papers. 
Manuscripts 
The manuscript title should be accurate, fully explanatory, and no longer than 12 words. 
The title should reflect the content and population studied. If the paper reports a 
randomized clinical trial, this should be indicated in the title. The title of brief reports 
should start with the words "Brief Report". 
The title page should include the names of all authors and their affiliations at the time 
the research was done. This information will be masked to ensure a blind peer review 
process by the editorial office. Authors should make sure that all other identifying 
information in the text of the paper is masked/removed prior to submission. 
All manuscripts must include a structured abstract containing a maximum of 250 words 
with the following sections: 
 Objective (brief statement of the purpose of the study); 
 Methods (summary of the participants, design, measures, procedure); 
 Results (primary findings); and 
 Conclusions (specific statement of the implications of the data). 
Please supply up to five keywords or brief phrases after the abstract. The Introduction 
should typically not exceed 3-4 pages in length. The paper should be referenced 
appropriately but excessive citations should be avoided. 
All research involving human participants must describe oversight of the research 
process by the relevant Institutional Review Boards and should describe consent and 
assent procedures briefly in the Methods section. 
All statistical tests should include effect size whenever possible. 
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First person language (“I”, “we”) should be avoided. Terminology should be sensitive 
to the individual who has a disease or disability. The journal endorses the concept of 
"people first, not their disability." Terminology should reflect the "person with a 
disability" (e.g., children with diabetes, persons with HIV infection, families of people 
with cancer) rather than the condition as an adjective (e.g., diabetic children, HIV 
patients, cancer families). Nonsexist language should be used. 
It is important to highlight the significance and novel contribution of the work. The 
translation of research into practice must be evidenced in all manuscripts. Authors 
should incorporate a meaningful discussion of the clinical and/or policy implications of 
their work throughout the manuscript, rather than simply providing a separate section 
for this material. 
Health Psychology publishes a broad array of types of papers. Authors of qualitative 
and measure development papers should read the guidelines for these types of papers, 
noted below. 
Qualitative Research 
Research papers that utilize qualitative methods should follow the general instructions 
to authors for style and format. We ask that authors of qualitative papers review the 
additional guidance below to assure that papers meet the following criteria utilized by 
Health Psychology. 
The introduction should make a compelling case for the significance of the study and 
clearly identify if the study is a stand-alone study or if it fits into a larger study. For 
example, qualitative manuscripts may inform the development of a survey, use small-
incident samples, or establish feasibility. The specific qualitative paradigm should be 
specified (e.g., grounded theory, qualitative descriptive approach, interpretive 
phenomenology) with a rationale as to why it was selected to address the research 
question. 
At the same time, authors are encouraged to avoid methodological tutorials and cite 
appropriate references for the methodology. Describe your sampling frame clearly and 
how the sample was selected, justifying the type and size of your sample using 
appropriate language for qualitative studies. 
While many qualitative studies may not use a conceptual model, if you have done so, 
explain how the model may have shaped the design, data collection, analysis and 
interpretation. Explain carefully how you strengthened and insured rigor in your study 
e.g., data analysis protocols (including how coders were trained), audit procedures, and 
demonstration of data saturation. Describe the data analysis and how it relates to your 
overall approach or paradigm. Present rich and compelling results with data that have 
been analyzed and interpreted appropriately for your method (e.g., discourse analytic 
results would be presented differently than those of a grounded theory). 
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The paper should convey how this research fills an important gap in the science and 
promises to change the way we approach future studies. 
Scale Development 
Empirical papers related to the development of new instruments related to health 
psychology should follow the general guidelines for style and format of this journal. 
Authors should make a convincing case for the need and rationale for the new 
instrument, particularly with respect to new and innovative constructs. Included in this 
rationale should be the theoretical foundation on which their new instrument rests along 
with presentation of other, related scales currently in use. 
It is important that the research have a degree of generalizability across populations and 
settings. Instruments that are more narrow in scope or of limited clinical utility may be 
better suited for subspeciality journals. 
Authors should clearly articulate the specifics of the study design and of the analytical 
techniques used. There should be strong consistency among the purpose statements, 
methods, and the manner in which findings are presented. 
An increasing number of studies are incorporating mixed-methods designs in their 
research. The specifics of these designs should be equally well-detailed without being 
excessive. Attention should be given to the nature of the items, the basis for their 
creation, and the rationale for the response options. 
The underlying theoretical structure of the approach should be evident, for example, 
whether one is premising their study on classical or modern theory (IRT, Rasch) 
techniques. The characteristics of the research will be in part dictated by the nature of 
the scale. For instance, large, nationally-normed tests may have a much different make-
up than that of small, more narrowly-defined measures. Research involving both types 
of instruments will be considered. 
Finally, all instrument development papers should convey how the literature base will 
be strengthened with the addition of the particular instrument along with a clear and 
convincing case for the clinical relevance of the information that it provides. 
Letters to the Editor 
Health Psychology will, at the discretion of the Editor-in-Chief, publish Letters to the 
Editor on the journal website. 
Letters should be prepared in direct response to articles published in the journal, should 
include reference to the published paper in the letter, and should be received through the 
Manuscript Submission portal within 60 days of the date when the relevant article is 
published in hard copy. 
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The text of the letter, excluding the title, references and author(s) name, title, affiliation 
and email, may not exceed 400 words. 
In a separate cover letter, the author should indicate that the submission is a Letter to the 
Editor for consideration of posting on the Health Psychology website and provide the 
full citation of the original article to which the letter refers. The cover letter should also 
indicate if the letter writer(s) have any conflicts of interest related to the article or 
correspondence. 
Masked Review Policy 
Masked review is used. Do not include author information (addresses, phone numbers, 
electronic mail addresses, and fax numbers) in the manuscript. 
Use of CONSORT Reporting Standards 
All randomized controlled trials must include a diagram indicating participant flow into 
the study and a completed CONSORT checklist. CONSORT diagrams (and adaptations) 
should be included whenever possible to clarify the flow of participants through a study. 
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Appendix 8 
Outline of positive psychology 
“Positive Psychology is the scientific study of the strengths and virtues that enable 
individuals and communities to thrive. This field is founded on the belief that people 
want to lead meaningful and fulfilling lives, to cultivate what is best within themselves, 
and to enhance their experiences of love, work, and play. 
 
Positive Psychology has three central concerns: positive emotions, positive individual 
traits, and positive institutions. Understanding positive emotions entails the study of 
contentment with the past, happiness in the present, and hope for the future. 
Understanding positive individual traits consists of the study of the strengths and 
virtues, such as the capacity for love and work, courage, compassion, resilience, 
creativity, curiosity, integrity, self-knowledge, moderation, self-control, and wisdom. 
Understanding positive institutions entails the study of the strengths that foster better 
communities, such as justice, responsibility, civility, parenting, nurturance, work ethic, 
leadership, teamwork, purpose, and tolerance.” 
 
Positive Psychology Centre (2007) Positive Psychology. Retrieved from 
http://www.ppc.sas.upenn.edu/ on 4
th
 May 2012. 
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Appendix 9 
List of forums/charities contacted for advertisement of Study 1 
http://www.mendedhearts.org/  
http://womenheart.clinicahealth.com  
http://www.heartcarecsg.co.uk  
http://heart119.org  
http://www.pacemakerclub.com/  
http://www.livewiresni.org  
http://www.healingwell.com/community/default.aspx?f=42  
http://forums.about.com/ab-heartdisease/  
http://www.healthboards.com/boards/forumdisplay.php?f=65 
http://network54.com/Hide/Forum/31466  
http://groups.yahoo.com/group/p_atrial_fib  
http://groups.yahoo.com/group/GodBlessMVPSville  
http://groups.yahoo.com/group/mitral_valve  
http://health.groups.yahoo.com/group/CABGheartbypasssupport/  
http://heartweb.co.uk/ 
http://www.heart2hearts.co.uk/ 
http://cardiacforum.org/forums/ 
http://www.medhelp.org/forums/Heart-Disease/show/114 
http://ehealthforum.com/health/heart_attack_symptoms.html 
http://www.heartboard.com/ 
http://www.revolutionhealth.com/forums/heart/coronary-artery-disease 
http://forums.ivillage.com/t5/Heart-Health/ct-p/iv-bharrhythmia 
http://upbeatheartsupport.org.uk/ 
http://www.heartsupportgroup.co.uk/ 
http://www.dailystrength.org/c/Coronary-Heart-Disease/support-group 
http://www.heartpatients.com/ 
http://community.bhf.org.uk/forum 
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Appendix 10 
Online advertisement for Study 1 
Hope and Heart Disease. 
Hope has been found to be an important predictor in the course of Heart Disease, but it 
is currently unknown what contributes to feelings of hope in people living with Heart 
Disease. I am conducting a research study as part of my Doctorate in Clinical 
Psychology at the University of Hull into just what these contributors are. The long-
term goal is to incorporate any findings into cardiac rehabilitation to foster hope and 
well-being. 
The study consists of a number of questionnaires which should take around 20 minutes 
to complete. If you wish to undertake the study please could you go to 
https://www.surveymonkey.com/s/hopeandheart and complete the survey. More 
information is available before the questionnaires which should hopefully answer any 
further questions you may have. Your time is greatly appreciated and you could be 
helping to improve the experiences of others living with heart disease! 
Many thanks, 
Owen Forster 
Chief Investigator 
o.forster@2009.hull.ac.uk 
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Appendix 11 
Ethical Approval Letter 
Removed for hard binding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
97 
 
Appendix 12 
Information sheet for Study 1 
 
Patient Information Sheet: Questionnaire Component 
We would like to invite you to take part in a research study. Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you. Please read this information carefully. If you have any questions that 
are not answered below please contact us before continuing. 
 
What is the purpose of the study? 
We are investigating what factors predict feelings of hope in individuals living with 
heart disease. It has been already found that higher levels of hope lead to lower 
mortality, but it is unknown what factors predict higher hope. If such factors were 
known then Cardiac rehabilitation programs could include a focus on these factors to 
hopefully foster feelings of hope in individuals living with heart disease.  
This study aims to find what those factors are. This study is being undertaken for 
educational purposes, as part of my doctorate in Clinical Psychology at the University 
of Hull. In addition, the results will be fed back to Humber Foundation Trust who may 
choose to publish the results in their own publications. It is also hoped that the results 
will be published in international journals and presented at conferences. 
 
Why have I been invited?  
You have been invited to take part because you are currently living with heart disease 
so we are interested in your experiences of hope and other factors. 
 
What will I be asked to do?  
You will be asked to complete a number of questionnaires concerning hope, 
depression, quality of life, social support, illness perception and control. They should 
take around 20 minutes to complete. 
 
Who can take part in the study? 
Not everyone living with heart disease is eligible to take part in the study. For inclusion 
in the study please ensure you meet the following criteria: 
 Must be currently living with a diagnosis of Heart Disease (This could be any 
type including coronary heart disease, heart attack, angina, cardiovascular 
disease, congestive heart failure, arrhythmia, cardiomyopathy etc.) 
 Over the age of 18. 
 No diagnosis of congenital heart disease (being born with a heart condition). 
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 No diagnosis of a serious mental health problem (this does not include anxiety 
or depression or any difficulties that have NOT needed psychological therapy). 
 No diagnosis of other serious on-going medical conditions (such as arthritis, 
diabetes or cancer).  
 Non-English speaking (All the questionnaires are available in English only). 
 
Do I have to take part and what if I change my mind?  
No, it’s up to you to decide to join the study; no-one will know if you decide to take 
part in the study or not. If you agree to take part in this survey, you may discontinue at 
any time by clicking on the ‘discontinue’ button shown on every page. If you 
discontinue your responses will not be saved and will not be used in the study. As the 
data is anonymous, once the survey has been submitted it cannot be withdrawn.  
Will my taking part in this study be confidential?  
No personally identifiable information will be collected during this study and survey 
monkey will not save your computer’s IP address. Therefore, we cannot trace your 
responses back to you and all data collected will be anonymous. Any information 
collected will be stored for up to a year after the completion of the study to allow for 
analysis, but will be destroyed thereafter. 
 
Potential Risks 
Some people may become distressed when completing this survey. If you do, you can 
discontinue at any time and your data will not be stored or used in the study. At the 
end of the survey (or if you decide to discontinue) a screen will be presented 
containing helpful resources, websites and contact numbers if you feel you need some 
support or further information. This information can also be found at the end of the 
paper version. 
 
Can I find out my results or what they mean?  
Since data will be collected anonymously we are not able to let you know your scores. 
At the end of the survey (or if you decide to discontinue) there will be a screen 
containing a link to a website where you can complete part of the questionnaire again 
and find out how to score and interpret your own responses.  
 
Expenses and payments 
You will not be paid for taking part in the study and you cannot claim any expenses. 
 
What are the possible benefits of taking part?  
We cannot promise this study will help you but it may raise  your awareness of your 
experiences of hope in relation to heart disease. The information we obtain from this 
study may help to understand what influences experiences of hope in individuals living 
with heart disease and may therefore benefit other people living with heart disease. 
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Who has reviewed this study?  
This study has been reviewed by the County Durham & Tees Valley Research Ethics 
Committee. It has also been peer reviewed by the research team at the Department of 
Clinical Psychology and Psychological Therapies at the University of Hull and is being 
sponsored by Humber Foundation Trust Research and Development. 
 
Further information and contact details 
The research is organised by Owen Forster, a trainee Clinical Psychologist employed by 
Humber Foundation Trust and training at the University of Hull. If you have a concern 
about any aspect of this study, or wish to ask any further questions you should contact 
him by email: o.forster@2009.hull.ac.uk 
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Appendix 13 
Consent form for Study 1 
 
 
 
CONSENT FORM 
Title of project: Predictors of Hope in Heart Disease 
Name of Researcher: Owen Forster 
1. I confirm that I have read and understand the information sheet 
dated 07 March 20101 (version 1.2), for the above study. I have 
had the  opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 

2. I understand that my participation is voluntary and that I am free 
to withdraw at any time without giving any reason, without any 
medical care or legal rights being affected. 
3. I understand that once I have submitted the survey it is not 
possible for my responses to be withdrawn since all the data is 
anonymous. 
4. I understand that data collected during the study may be looked 
at by individuals from the University of Hull, from regulatory 
authorities or from the NHS Trust, where it is relevant to their 
taking part in this research. I give permission for these individuals 
to have access to the data. 

5. I am aware of the potential risks and benefits of taking part. 
6. I agree to take part in the above study 
 
 
 
 
 
 
 
Please tick the box 
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Appendix 14 
Internet survey questions converted to text format 
Demographic Information 
 
Please could you answer the following questions. 
 
The information gathered here will not enable yourself to be identified by anyone 
involved with the study. Your responses will remain anonymous. 
 
1. How old are you? 
 
2. Sex 
□ Male 
□ Female 
 
3. In which country do you currently live? 
 
4. Ethnicity 
 
5. Which heart related diagnoses have you received? 
 
6. How many months has it been since you received your first diagnosis? 
 
7. Which of the following options would best describe your current experience of 
your diagnosis? 
□ No symptoms and no limitation in ordinary physical activity e.g. shortness of 
breath when walking, climbing stairs etc. 
□ Mild symptoms (mild shortness of breath and/or angina) and slight limitations 
during ordinary activity) 
□ Marked limitations in activity due to symptoms, even during less-than-ordinary 
activity e.g. walking short distances (20-100m). Comfortable at rest. 
□ Severe limitations. Experiences symptoms even when at rest. Mostly bedbound. 
 
8. Have you any experience of friends and/or relatives living with heart disease? 
□ Yes 
□ No 
 
 
Herth Hope Scale: Removed for hard binding. 
 
Cardiac Depression Scale: Removed for hard binding. 
 
Illness Perception Questionnaire: Removed for hard binding. 
 
MacNew Health Related Quality of Life Questionnaire: Removed for hard binding. 
 
Multidimensional Health Locus of Control Scale: Removed for hard binding. 
 
Duke-UNC Functional Social Support Questionnaire: Removed for hard binding. 
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Appendix 15 
 
Information sheet for Study 2 
 
 
 
Patient Information Sheet: Interview  Component 
We would like to invite you to take part in a research study. Before you decide 
we would like you to understand why the research is being done and what it 
would involve for you. Please read this information carefully. If you have any 
questions that are not answered below please contact us before continuing. 
 
What is the purpose of the study? 
We are investigating what factors predict feelings of hope in individuals living 
with heart disease. It has been already found that higher levels of hope lead to 
lower mortality, but it is unknown what factors predict higher hope. If such 
factors were known then Cardiac rehabilitation programs could include a focus 
on these factors to hopefully foster feelings of hope in individuals living with 
heart disease.  
This study aims to find what those factors are. This study is being undertaken 
for educational purposes, as part of my doctorate in Clinical Psychology at the 
University of Hull. In addition, the results will be fed back to Humber Foundation 
Trust who may choose to publish the results in their own publications. It is also 
hoped that the results will be published in international journals and presented 
at conferences. 
 
What will I be asked to do?  
If you decide to take part then upon making contact with the researcher they will 
arrange with you a time for the researcher to come and interview you. The 
interview will last approximately 45 minutes and will cover a variety of topics 
around hope and heart disease. You may also, if you wish to, be asked to 
participate in the interpretation of the findings, but that will be discussed at time 
of interview.  
Who can take part in the study? 
Not everyone living with heart disease is eligible to take part in the study. For inclusion 
in the study please ensure you meet the following criteria: 
 Must be currently living with a diagnosis of Heart Disease (This could be any 
type including coronary heart disease, heart attack, angina, cardiovascular 
disease, congestive heart failure, arrhythmia, cardiomyopathy etc.) 
 Over the age of 18. 
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 No diagnosis of congenital heart disease (being born with a heart condition). 
 No diagnosis of a serious mental health problem (this does not include anxiety 
or depression or any difficulties that have NOT needed psychological therapy). 
 No diagnosis of other serious on-going medical conditions (such as arthritis, 
diabetes or cancer).  
 Non-English speaking 
 
 
Do I have to take part and what if I change my mind?  
No, it’s up to you to decide to join the study; no-one will know if you decide to 
take part in the study or not. If you agree to take part then the researcher will 
arrange with you a time that is convenient with you to participate in the 
interview, at a location of your choosing. If you change your mind about taking 
part, either before or after interview, then all information about yourself will be 
removed from the research study. 
 
Will my taking part in this study be confidential?  
Due to the nature of the interview some potentially identifiable may be included. 
All interviews will be recorded by the researcher and then transcribed. During 
the transcription process pseudonyms will be used to ensure anonymity. Once 
transcription has taken place the original recordings will be destroyed. Any 
information will be kept for a maximum of 12 months. Additionally, it is 
necessary that your GP is informed of your participation in the study. GPs will 
only be made aware that you have participated in a research interview 
regarding heart disease and experiences of hope. No other information will be 
provided to your GP. 
 
Potential Risks 
Some people may become distressed when completing the interview. If you do, 
please inform the interviewer. You are also free to withdraw at any time, with no 
penalty or consequence, and all your data will be removed from the study. At 
the end of the interview the researcher will provide information on helpful 
resources, websites and contact numbers if you feel additional support. 
What are the possible benefits of taking part?  
We cannot promise this study will help you but it may raise your awareness of 
your experiences of hope in relation to heart disease. The information we obtain 
from this study may help to understand what influences experiences of hope in 
individuals living with heart disease and may therefore benefit other people 
living with heart disease. 
 
Can I find out my results or what they mean?  
A number of interviews are being carried out, and all responses looked at 
collectively with the aim of finding common experiences among numerous 
individuals. As such individual results will not be produced. However, if you wish 
to receive a copy of the completed results please inform the researcher. 
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Expenses and payments 
You will not be paid for taking part in the study and you cannot claim any 
expenses. 
 
Who has reviewed this study?  
This study has been reviewed by the County Durham & Tees Valley Research 
Ethics Committee. It has also been peer reviewed by the research team at the 
Department of Clinical Psychology and Psychological Therapies at the 
University of Hull and is being sponsored by Humber Foundation Trust 
Research and Development. 
 
Further information and contact details 
The research is organised by Owen Forster, a trainee Clinical Psychologist 
employed by Humber Foundation Trust and training at the University of Hull. If 
you wish to take part in the study please contact Owen Forster to arrange 
a time and place for the interview to happen. His contact details are: 
Email:  o.forster@2009.hull.ac.uk Telephone: 07904 302 319 
If you are interested in helping further, a questionnaire study is being run 
alongside the interview study. If you would like to complete the questionnaire 
study please go to https://www.surveymonkey.com/s/hopeandheart where you 
will find more information and the questionnaires. 
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Appendix 16 
Consent form for Study 2 
Participant Identification number for this study: 
Pseudonym: 
CONSENT FORM 
Title of project: Predictors of Hope in Heart Disease 
Name of Researcher: Owen Forster 
1. I confirm that I have read and understand the information sheet dated 
07 March 2011 (version 1.2), for the above study. I have had the  
opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 

2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without any medical care 
or legal rights being affected. 
3. I understand that that at any point should I wish to withdraw my 
participation my data will be removed from the present study and  it will 
be destroyed. 
4. I understand that data collected during the study may be looked at by 
individuals from the University of Hull, from regulatory authorities or from 
the NHS Trust, where it is relevant to their taking part in this research. I 
give permission for these individuals to have access to the data. 

5. I am aware of the potential risks and benefits of taking part. 
6. I consent to the interview being audio recorded by the researcher, and 
for the recording to be transcribed using a pseudonym. 
7. I consent for my GP to be informed of my participation in the research 
study. 
8. I agree to take part in the above study 
 
____________________  ____________        ____________________ 
Name of participant     Date    Signature 
____________________  ____________        ____________________ 
Person taking consent       Date    Signature 
 
Please initial the box 
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Appendix 17 
Interview schedule 
Predictors of hope in heart disease: Semi-structured interview schedule 
 
Information gathering 
Demographic information: age, sex, ethnicity. 
Diagnosis, disease severity and time since diagnosis 
Previous experiences of heart disease 
 
Hope 
What have been your experiences of hope since your diagnosis? 
Could you tell me if you have experienced hope, or not feeling hopeful, in 
relation to your illness? 
 Have your feelings of hope changed over time? If so, how? 
 Can you talk about a time you have felt particularly hopeful in regards to your 
illness? 
 And how about a time when you did not feel hopeful? 
 
Depression 
Have you had times that you’ve experienced low mood and has this affected any 
experiences of hope you have had? 
 Have there been times when you've felt low/sad/depressed, and if so could you 
discuss them? 
 How did any changes in your mood been relate to feelings of hope you were/are 
having? 
 
Illness Perception 
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How do you see your illness and has this affected any experiences of hope you have 
had? 
 Has your perception of your illness changed over time? If so, has this affected 
any experiences of hope you’ve had? 
 
Quality of life 
How would you rate your current quality of life and has this affected any experiences 
of hope you have had? 
 Has your quality of life been changeable since your diagnosis? Have there been 
times where things have been better or worse, and could you talk about these times? 
 Have any changes in your quality of life affected any experiences of hope you’ve 
had? 
Locus of control  
How in control of your illness do you feel and has this affected any experiences of hope 
you have had? 
 Where would you say the control lay? With you or with other people, and that 
could include medical professionals as well? 
 Has there been any change over time in who has been in control of your illness? 
If so, has this had any impact on any experiences of hope you’ve had? 
 
Social support 
What have been your experiences of receiving support from people you know and has 
this affected any experiences of hope you have had? 
 Has this support been consistent or has it changed over time? 
 Have your experiences of support from those around you had any relation to 
any feelings of hope you were/are having? 
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Other 
Are there any other areas apart from those already discussed that you feel have had 
an impact on your experiences of hope? 
 How have these affected your experience of hope? 
 Has this been consistent over time or has it been variable? 
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Appendix 18 
Linear regression output 
 
Variables Entered/Removed
b
 
Model 
Variables 
Entered 
Variables 
Removed Method 
1 NYAA
a
 . Enter 
2 LoCChance, 
LoCInternal, 
SocialSup, 
Depression, 
QoL, IllnessP
a
 
. Enter 
a. All requested variables entered. 
b. Dependent Variable: Hope 
 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .209
a
 .044 .035 4.794 
2 .719
b
 .517 .485 3.502 
a. Predictors: (Constant), NYAA 
b. Predictors: (Constant), NYAA, LoCChance, LoCInternal, SocialSup, 
Depression, QoL, IllnessP 
 
 
 
ANOVA
c
 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 115.014 1 115.014 5.004 .027
a
 
Residual 2528.093 110 22.983   
Total 2643.107 111    
2 Regression 1367.377 7 195.340 15.924 .000
b
 
Residual 1275.730 104 12.267   
Total 2643.107 111    
a. Predictors: (Constant), NYAA 
b. Predictors: (Constant), NYAA, LoCChance, LoCInternal, SocialSup, Depression, QoL, IllnessP 
c. Dependent Variable: Hope 
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Coefficients
a
 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) 40.938 1.217  33.628 .000 
NYAA -1.264 .565 -.209 -2.237 .027 
2 (Constant) 38.002 5.915  6.425 .000 
NYAA .926 .529 .153 1.751 .083 
Depression -.128 .030 -.602 -4.253 .000 
IllnessP .045 .062 .116 .736 .463 
QoL .809 .596 .185 1.358 .178 
LoCInternal .089 .057 .116 1.567 .120 
LoCChance -.023 .058 -.029 -.389 .698 
SocialSup .660 .480 .114 1.376 .172 
a. Dependent Variable: Hope 
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Appendix 19 
Worked example of Interpretive Phenomenological Analysis: Creation of themes 
 
A section of transcript form one participant is shown here to illustrate each stage of the IPA 
process. This is an excerpt from a male participant who has undergone a triple bypass 
operation 2 years prior to interview. 
 
Extract of transcript: 
 
What about after the operations? How were you feeling then, emotionally? 
 
Erm, emotionally, erm, well, I said to you, you know, during the first four weeks or so I was 
thinking, “is this it? is this the best I’m gonna get? Am I ever going to better than this?” And 
that was like, that was not a particularly pleasant feelings, thinking that was going to be me for 
the rest of my days, because of my heart. So, that was a bit of a depression. A bit of a downer 
was that one. Erm, but yeah, the thing was, I don’t know, I’m used to cuts and bruises and 
breaks in life, but you can see your progress on a day to day thing with cuts and bruises and 
things like that. But with this, there was no, it was like, the progress was that slow, it was like, 
sometimes it wasn’t even on a week to week basis, like a fortnightly basis, you know. It was 
like a fortnight before you start, before I start to felt that much better than that, you know. It 
was like progress was that slow, so so slow. And it was, erm, not a pleasant time to tell you the 
truth. 
 
Did your mood lift as you improved? 
 
Yeah, it did yeah. Yeah. Oh yeah. That’s sort of like, erm, went hand in hand with how you’re 
feeling when you’re not very well. You’re not much of a fun person to be around are you? But 
when you start improving and that, your smile comes back, and you start telling jokes again 
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and things like that, you know. And you know you’re on your way. I know I’m not fully 
recovered yet, but I feel a lot better than I did four months ago. 
 
Is it helpful to look back and see the distance? 
 
Yeah. I mean my partner is lovely, she keeps, you know, I keep saying to her “ I should be doing 
this. I should be back playing golf and fishing” and she says, she just says, “Just slow down, just 
slow it down, slow it down”, you know. Erm, I want things to happen quicker than my body is 
letting me, and erm, she’s telling me to slow down. It’s all a bit of a strange thing, but I’m 
getting there. 
 
What has been your experience of receiving support from people around you? 
 
From around me, yeah, oh yeah. My partner, family and that. It’s been really good. From the 
health service, haha, don’t even ask me about that!. There just isn’t any. There is nothing.  
 
So it was up to the people around you to give the support then? 
 
Yeah, yeah. 
 
How was that for you? Was it good support? 
 
Yeah, really good, yeah. But from, I mean, I got to thinking, if I’d not been, or somebody else 
who, you know, in my situation regarding the operation and that, had not had the support that 
I had, I was thinking, “how would they have coped?” you know. I tell you, they wouldn’t have 
coped very well. 
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Stage One Analysis 
Transcripts were read twice to facilitate understanding of the whole text. 
 
Stage Two Analysis 
The researched noted statements on topics of interest, contradictions, similarities and use of 
language. Stage Two was also completed by a Trainee Clinical Psychologist (female, 4 
transcripts). 
 
 
 
Asking difficult questions of 
self. 
 
 
Negative outlook  
 
 
Remembering past 
recovery/strength. 
Comparing past and present. 
Recognising a different 
timescale. 
 
Recognising small steps 
towards recovery. 
Enduring unpleasantness. 
 
 
 
 
Getting back to normal. 
 
 
What about after the operations? How were you feeling then, 
emotionally? 
 
Erm, emotionally, erm, well, I said to you, you know, during the 
first four weeks or so I was thinking, “is this it? IS this the best 
I’m gonna get? Am I ever going to better than this?” And that 
was like, that was not a particularly pleasant feelings, thinking 
that was going to be me for the rest of my days, because of my 
heart. So, that was a bit of a depression. A bit of a downer was 
that one. Erm, but yeah, the thing was, I don’t know, I’m used 
to cuts and bruises and breaks in life, but you can see your 
progress on a day to day thing with cuts and bruises and things 
like that. But with this, there was no, it was like, the progress 
was that slow, it was like, sometimes it wasn’t even on a week 
to week basis, like a fortnightly basis, you know. It was like a 
fortnight before you start, before I start to felt that much 
better than that, you know. It was like progress was that slow, 
so so slow. And it was, erm, not a pleasant time to tell you the 
truth. 
 
Did your mood lift as you improved? 
 
Yeah, it did yeah. Yeah. Oh yeah. That’s sort of like, erm, went 
hand in hand with how you’re feeling when you’re not very 
well. You’re not much of a fun person to be around are you? 
But when you start improving and that, your smile comes back, 
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Socialising returning to 
normal. Humour. Realising 
recovery is a long term 
process. Recognising 
recovery. 
 
 
 
Family support. 
Wanting to be active. 
 
Other’s remembering limits. 
Trusting that she is looking 
out for him. 
Recovery. 
 
 
 
 
Family support. 
Let down by health service. 
Wanting experts. 
 
 
 
 
 
 
 
 
 
Relying upon family when 
times are difficult. 
Seeing situation for what it 
is. Knowing what needs are. 
and you start telling jokes again and things like that, you know. 
And you know you’re on your way. I know I’m not fully 
recovered yet, but I feel a lot better than I did four months ago. 
 
Is it helpful to look back and see the distance? 
 
Yeah. I mean my partner is lovely, she keeps, you know, I keep 
saying to her “I should be doing this. I should be back playing 
golf and fishing” and she says, she just says, “Just slow down, 
just slow it down, slow it down”, you know. Erm, I want things 
to happen quicker than my body is letting me, and erm, she’s 
telling me to slow down. It’s all a bit of a strange thing, but I’m 
getting there. 
 
What has been your experience of receiving support from 
people around you? 
 
From around me, yeah, oh yeah. My partner, family and that. 
It’s been really good. From the health service, haha, don’t even 
ask me about that! There just isn’t any. There is nothing.  
 
So it was up to the people around you to give the support 
then? 
 
Yeah, yeah. 
 
How was that for you? Was it good support? 
 
Yeah, really good, yeah. But from, I mean, I got to thinking, if 
I’d not been, or somebody else who, you know, in my situation 
regarding the operation and that, had not had the support that 
I had, I was thinking, “how would they have coped?” you know. 
I tell you, they wouldn’t have coped very well. 
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Stage Three Analysis 
Emerging themes (including the researchers and colleagues interpretations, were documented 
in the right hand margin. 
 
 
 
 
Asking difficult 
questions of self. 
 
 
 
 
Negative outlook  
 
 
 
 
Remembering past 
recovery/strength. 
Comparing past and 
present. Recognising a 
different timescale. 
 
Recognising small 
steps towards 
recovery. 
 
 
Enduring 
unpleasantness. 
 
 
 
What about after the operations? How 
were you feeling then, emotionally? 
 
Erm, emotionally, erm, well, I said to you, 
you know, during the first four weeks or so 
I was thinking, “is this it? IS this the best 
I’m gonna get? Am I ever going to better 
than this?” And that was like, that was not 
a particularly pleasant feelings, thinking 
that was going to be me for the rest of my 
days, because of my heart. So, that was a 
bit of a depression. A bit of a downer was 
that one. Erm, but yeah, the thing was, I 
don’t know, I’m used to cuts and bruises 
and breaks in life, but you can see your 
progress on a day to day thing with cuts 
and bruises and things like that. But with 
this, there was no, it was like, the progress 
was that slow, it was like, sometimes it 
wasn’t even on a week to week basis, like 
a fortnightly basis, you know. It was like a 
fortnight before you start, before I start to 
felt that much better than that, you know. 
It was like progress was that slow, so so 
slow. And it was, erm, not a pleasant time 
to tell you the truth. 
 
Did your mood lift as you improved? 
 
Yeah, it did yeah. Yeah. Oh yeah. That’s 
sort of like, erm, went hand in hand with 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perspective/knowledge: 
recognising recovery. 
 
Perspective/knowledge: 
Timescales 
 
 
Perspective/knowledge: 
recognising recovery 
 
 
 
Inner resources: mental 
strength 
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Getting back to 
normal. 
 
 
 
 
Socialising returning 
to normal. Humour. 
Realising recovery is a 
long term process. 
Recognising recovery. 
 
 
 
 
Family support. 
Wanting to be active. 
 
 
Other’s remembering 
limits. Trusting that 
she is looking out for 
him. 
 
Recovery. 
 
 
 
 
 
 
Family support. 
Let down by health 
service. Wanting 
how you’re feeling when you’re not very 
well. You’re not much of a fun person to 
be around are you? But when you start 
improving and that, your smile comes 
back, and you start telling jokes again and 
things like that, you know. And you know 
you’re on your way. I know I’m not fully 
recovered yet, but I feel a lot better than I 
did four months ago. 
 
Is it helpful to look back and see the 
distance? 
 
Yeah. I mean my partner is lovely, she 
keeps, you know, I keep saying to her “I 
should be doing this. I should be back 
playing golf and fishing” and she says, she 
just says, “Just slow down, just slow it 
down, slow it down”, you know. Erm, I 
want things to happen quicker than my 
body is letting me, and erm, she’s telling 
me to slow down. It’s all a bit of a strange 
thing, but I’m getting there. 
 
What has been your experience of 
receiving support from people around 
you? 
 
From around me, yeah, oh yeah. My 
partner, family and that. It’s been really 
good. From the health service, haha, don’t 
even ask me about that! There just isn’t 
any. There is nothing.  
 
So it was up to the people around you to 
 
 
 
 
 
 
Environment: social 
consistency. 
Inner resources: mental 
strength/staying active. 
Perspective/knowledge: 
recognising recovery. 
 
 
 
 
 
Environment: family 
support. 
 
Inner resources: staying 
active, adaptability. 
Perspective/knowledge; 
knowing your limits, 
congruence of needs, 
recognising recovery. 
Inner resources: 
trusting in others. 
 
 
 
 
 
 
Environment: family 
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experts. 
 
 
 
 
 
 
 
 
 
 
Relying upon family 
when times are 
difficult. 
Seeing situation for 
what it is. Knowing 
what needs are. 
give the support then? 
 
Yeah, yeah. 
 
How was that for you? Was it good 
support? 
 
Yeah, really good, yeah. But from, I mean, I 
got to thinking, if I’d not been, or 
somebody else who, you know, in my 
situation regarding the operation and that, 
had not had the support that I had, I was 
thinking, “how would they have coped?” 
you know. I tell you, they wouldn’t have 
coped very well. 
support 
 
 
 
 
 
 
 
 
 
 
 
 
 
Environment: family 
support 
Perspective/knowledge: 
congruence of needs, 
seeing the big picture. 
Inner resources: 
trusting others, mental 
strength. 
 
 
Stage Four Analysis 
Quotes form all participants’ transcripts were grouped into relevant themes to establish 
comparisons. Emerging themes were with colleagues and two participants. This provided peer 
and member validation for the emerging themes. 
Emerging Theme Supporting Quotes 
Mental Strength 
 
 
Taking control 
 
“if you let that [the head] go, then that’s dead 
[the heart]” 
“I won’t be beat” 
“it’s down to people to decide for themselves 
what to do” 
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Trusting other people 
 
 
Staying active 
 
Adaptability 
 
 
 
 
 
Family support  
Using experts 
 
 
Social consistency 
Positive modelling 
 
 
Knowing limits 
Timescale 
 
Congruence of needs 
 
 
Seeing a bigger picture 
 
Recognising recovery 
“give my body over to the doctor and let him 
deal with it…I did that” 
“you just place your trust in their hands” 
“I still carried on with what I was doing e.g. 
golfing, gardening, walking…” 
“I had to take time off work…but I carried on 
strong” 
 “I’ve got more confident…I don’t stand back 
and wait” 
“if it’s very cold at the football I have to get 
double wrapped up now” 
“they’ve always been there for you” 
“I’m doing what the doctors tell me” 
“you get the information from the specialist 
about…what you can do” 
“they never stopped inviting me” 
“”I had one [a heart attack] three years ago” 
and with that he shoved a boiler on his back 
and I thought “oh well!”” 
“I’m sensible in what I can and cannot do” 
“just got to realise that it does take 
time…which I didn’t realise at the time” 
“I’d say “a little further” and the wife would 
say “now, you’ve got to get back”, it’s a good 
reminder” 
“it’s a hazard of life. A bump in the road, 
that’s all” 
“I was able to walk a bit further and when I 
could drive. It was all milestones on the way 
to recovery” 
 
Stage Five Analysis 
Connections between themes were made across transcripts to develop super-ordinate 
themes. These were then compared to transcripts and themes were included if they were 
present in over half of the sample. 
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Appendix 20 
Reflective statement 
Introduction 
This is a statement reflecting upon the research process, from formulation of research 
questions and systematic literature review through to completion of the empirical study 
with its quantitative and qualitative components. I aim to give a personal account of this 
process as well as allowing reflection upon decisions made and knowledge gained. 
Formulation of a research question 
The idea to undertake health psychology research was not my own. When I was given 
the chance to choose a research direction at the beginning of the process I chose to 
undertake research into bipolar disorder. Unfortunately, shortly after the 
commencement of this my supervisor retired and it was judged to be better to start 
afresh. At this stage I had already formulated some ideas about looking at positive 
concepts so these were carried over to look at the field of health psychology. This was 
an incredibly broad starting position, so I sought to narrow down the scope of the 
project. My supervisor suggested that heart conditions might be a good place to start, as 
they are generally less researched than cancer and palliative diseases.  
With this in mind, I began looking into positive aspects of health in people living with 
cardiac illness. I began searching quite widely, and in this process happened upon a 
study which grabbed my interest. A literature review of qualitative studies found that 
hope was a significant factor in illness trajectory (Davidson, Dracup, Phillips, Daly & 
Padilla, 2007). Immediately, I sought to explore hope in heart disease more fully, 
expecting a wealth of literature. What I discovered was simultaneously disappointing 
and galvanising. I could only find a small handful of studies that investigated hope in 
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cardiac illness, with little coherent direction between them. As a result, the first question 
that came to mind was the one that ended up being born out in the research, what makes 
people hopeful? 
Choice of methodology 
The choice to use quantitative methods was a simple one. I was looking for statistical 
predictors and I am comfortable with questionnaires and numbers. The inclusion of 
qualitative methodology primarily emerged through conversations within the 
department. Every person I talked to had a different concept of hope, and felt that this 
would possibly apply to my research population as well. The means to get to these 
individuals beliefs was through the use of interviews. I was somewhat apprehensive that 
this would mean extra work but felt confident that it would allow a much better analysis 
and understanding of the topic, which I feel now it did. 
Systematic Literature Review 
I approached my systematic literature review somewhat cautiously. I have never 
conducted a review and was aware that it was necessary to include all studies in a 
defined area. As a result a rather lengthy period was spent searching, refining and 
reading as I was determined to ensure that no stone was left unturned. While this was a 
time consuming process, it also allowed me to immerse myself in the literature which 
was very helpful when it came to discussing the findings of the review. 
If I were to conduct another review, which is something that happily does not fill me 
with dread, I think I would still adopt a thorough approach but maybe that it would be 
less stressful for me to do so. With hindsight, I would also prefer to be researching a 
term that unlike „hope‟, is not used in common parlance and therefore results in 
thousands of search results. 
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The review was written for Health Psychology Review. This was not only because the 
journal has a good impact factor but also because unlike many other journals it does not 
have a word limit on reviews. I found this attractive because while intent on writing a 
concise piece the sense of not having a fixed ending allowed me to fully and freely 
explore discursive thinking. 
Ethics 
My progress through ethics was a very different one from many of my peers. I initially 
approached Proportionate review. My study was not deemed appropriate for this, but in 
a fortunate twist, the organiser of the proportionate review was able to get my study 
reviewed by a full ethical committee within the week. While this was positive in terms 
of timescale, it meant I was unable to attend my committee due to existing 
commitments. At it turned out there were only a few alterations required to the study 
but it is one regret that during the research process I did not receive the experience of 
attending a REC meeting.  
Empirical Study 
I remember having some apprehension about researching into hope. I think knowing 
that I would potentially be encountering people who were not very hopeful about their 
illness and their future was something that I found difficult. In retrospect, this was not 
the case however, with all the individuals I met along my journey being hopeful and 
enthusiastic, which was certainly something which helped. Reflecting on my own 
feelings of hope there were times throughout the research where my own feelings of 
hope were quite low, especially in regards to recruitment. When looking at the themes 
that came through in study 2 I can definitely identify that seeing the big picture and 
recognising progress as being things that helped me rediscover hope in times of 
difficulty. I think by understanding the processes behind hope, and going through them 
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myself, has given me great insight in how people approach their difficulties and this is 
something I will be taking with me into my clinical work. 
Epistemological Statement 
This study is based on the premise that truth can exist in many forms, and the truth that 
you discovered will depends on your approach towards truth. As such, this study took 
two different approaches to discovering the truth. Statistical methods will produce a 
version of the truth that is replicable, but that is limited by both the variables 
investigated and the analysis conducted. Qualitative methods will not produce a 
replicable version of the truth, it will be hugely affected by those interviewed and by 
those carrying out the analysis. It will, however, produce a truth that is less limited by 
the questions asked as there is space for individuals to fill in gaps with their own truth. I 
recognise that this approach has left great space for contradiction and disagreement in 
truths, but by doing so will allow more truths to become evident. 
Study 1 
Finding relevant measures for the variables was not difficult, but finding brief measures 
was more of a challenge. I was keen that questionnaires be as brief as possible due to 
the number of variables, whilst still being valid. Thankfully, brevity was an approach 
already favoured by researchers in CVD, so it was possible to identify brief measures 
through examination of the existing literature. 
I encountered a dilemma when it came to sample size calculations. If I were to include 
every subscale of the selected questionnaires my sample size would have been 
incredibly difficult to achieve. I therefore made the decision to use the overall scales 
from the chosen questionnaires (with the exception of the MHLoC which does not have 
one). Whilst this somewhat limited the exploratory nature of the study, it did allow for 
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focused analysis and discussion of the predictors. In regards to methodology I was 
aware of the inherent self-selecting bias. Those viewing the advertisement were already 
participating in online discussions about their illnesses so were potentially not 
representative of the population as a whole. However, I feel that because the results 
were able to be understood in the context of subjective experience from those in Study 2 
that I am comfortable that the results are valid. 
Study 2 
Having never conducted qualitative research before I was quite nervous in the 
preparation for this study. Despite meeting people on a daily basis in my clinical role it 
felt as though I was starting afresh when it came to research. This feeling quickly 
dispersed as I began my first interview and found my participant open, warm and 
reflective. In fact, my overall experience with participants was incredibly enlightening 
with all those taking part giving more pieces to add to the puzzle. 
Following the completion of the interviews I was keen to begin the IPA because I felt 
that so much good information had been provided to me by my participants, and that I 
wanted to do it justice in my analysis. Through conducting the IPA I feel I was able to 
gain a much greater understanding not only into the themes around hope, but the nature 
of hope itself which was invaluable in the writing up process. I believe I learnt a great 
deal from doing the qualitative study and feel that in the future I would have no 
reservations about conducting qualitative research again. 
Conclusion 
I am very satisfied with my doctoral project. I feel I have learnt so much in so many 
areas, from time management to writing up. At time the process was difficult, and 
caused my hope to fluctuate, but I feel that following this process I am well equipped to 
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go on and conduct research in the future. Reflecting on the process on the whole I can 
see now how things could have been done in a different and more efficient manner, but 
without that I would not have learnt as much as I have. 
 
